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ABSTRACT 
 
ROLE OF THE GLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE, Gpc1, IN 
PHOSPHATIDYLCHOLINE (PC) BIOSYNTHESIS AND REMODELING IN 
SACCHAROMYCES CEREVISIAE 
 
 
By 
Sanket Pramod Anaokar 
May 2019 
 
Dissertation supervised by Dr. Jana Patton-Vogt. 
Biomembranes are permeable barriers that enclose the cell and the intracellular organelles 
in a cell. The selective nature of these robust barriers acts as the first line of defense towards the 
harsh factors that can compromise cell survival. Biomembranes primarily consist of membrane 
lipids that are organized into layers to form a dynamic bilayer structure. The dynamic nature of 
the membrane requires the synchronized modulation of lipid composition through de novo 
synthesis, degradation, intracellular movement, and remodeling. Phospholipids are the major 
membrane lipid class, and phosphatidylcholine (PC) is the most abundant phospholipid in most 
eukaryotic biomembranes.  
PC is primarily produced via two major pathways: the Kennedy and PE methylation 
pathways. Through a collaborative project, we have discovered a lipid-modifying enzyme, a 
glycerophosphocholine acyltransferase, Gpc1, involved in a new pathway for PC biosynthesis and 
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PC remodeling. Here, I have examined this alternative route for PC biosynthesis and remodeling 
using Saccharomyces cerevisiae (S. cerevisiae) as a model organism. First, I performed in vivo 
metabolic labeling studies to delineate the role of Gpc1 in the alternative route for PC biosynthesis. 
I have also determined the apparent molecular weight of this novel Gpc1 protein by constructing 
a C-terminal epitope tag followed by Western blot analysis. These studies are described in more 
detail in Chapter two. 
In the second half of my dissertation, I have examined the physiological function and 
regulatory aspects of Gpc1. Using LC-MS analysis, I have determined the PC species profile 
generated via this alternative pathway. Gpc1 was found to be involved in a PC 
deacylation/reacylation remodeling pathway (PC-DRP) that results in an increase in 
monounsaturated PC species at the expense of diunsaturated PC species. Here, I report inositol, a 
phospholipid precursor, as a down-regulator for GPC1 expression. Also, I have identified a 
phenotype associated with the loss of GPC1. Loss of GPC1 results in decreased cell viability for 
cells at the stationary phase. These studies are described in detail in Chapter three. Overall, in 
Chapters two and three, I have identified Gpc1 as a member of PC-DRP, a pathway that increases 
the saturation state of the PC. This increase may impact on the physiochemical properties of the 
membrane.  
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Chapter 1: Introduction 
1.1. Saccharomyces cerevisiae as a model organism to explore membrane lipids 
 
Saccharomyces cerevisiae (S. cerevisiae) is a eukaryotic unicellular fungus known as the 
budding yeast. This unicellular fungus exists in both diploid and haploid states. Employing S. 
cerevisiae as a model organism has proven to be beneficial in understanding the biochemistry, 
molecular biology, and cell biology of lipids. There are many advantages to be gained by using 
S.  cerevisiae as a model organism. For example, the doubling time for yeast is 90 minutes, this 
shorter generation time allows for faster culture saturation. The components in the medium can be 
altered depending on the aim of the experiment. The yeast deletion collection [1], auxotrophic 
markers, and drug-resistant markers are available for ease of genetic modification. The 
Saccharomyces Genome Database (SGD; http://www.yeastgenome.org), and linked websites such 
as Yeastract (http://www.yeastract.com) provide wealth of information on almost every aspect of 
characterized or uncharacterized ORFs. Accessible information includes potential transcription 
factors, cellular localization of gene products, gene expression data and protein-protein 
interactions.    
The following are specific benefits of using S. cerevisiae as a model system to study lipids. 
First, the biochemical pathways necessary for cellular functioning in S.  cerevisiae, including the 
lipid metabolism, show a high degree of similarity to the higher eukaryotes. S. cerevisiae lacks 
polyunsaturated lipids, making their lipid profile easier to study. The genetic tractability of this 
organism allows for the facile construction of the gene knockouts, overexpressors, and epitope 
tags. Components of the medium, such as the inclusion of inositol and choline, have a significant 
impact on the lipid profile. Thus, the ability to work with the defined medium allows the 
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researcher to have control over the physiological and biochemical parameters affecting the lipid 
profile.  
 
1.2. Overview of the major classes of membrane lipids in S. cerevisiae 
 
 
 
Phospholipids have a glycerol backbone, while sphingolipids have a ceramide backbone. 
Phospholipids have acyl chains at sn-1 and sn-2 positions of the glycerol backbone. Backbones 
and headgroups are highlighted in yellow boxes and red circles, respectively. Hydroxyl and oxygen 
moieties are denoted in red text. The structures were obtained from the LIPID MAPS database 
(https://www.lipidmaps.org/). 
 
Biomembranes are bilayer structures consisting of lipids and proteins. Biomembranes act 
as barriers between the intracellular compartments of a cell and its cytosol, and between a cell and 
its environment. Each of these lipid layers has hydrophobic acyl chains directed inwards to create 
a hydrophobic core, while the hydrophilic headgroups interact with the outer or inner aqueous 
environment of a cell. The proteins associated with the lipid bilayer perform vital functions 
including the transportation of metabolites, responding to external stimuli and assistance in energy 
Figure 1. 1. Major classes of membrane lipids in yeast. 
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transduction [2-4]. The major classes of membrane lipids (Fig 1.1) include phospholipids, 
sphingolipids and ergosterol [5, 6]. In yeast, phospholipids make up 70% of the membrane lipids, 
while sphingolipids and ergosterol account for the remaining amount [6].  
 
 
  
Phospholipids are classified based upon the head group that is attached at the sn-3 position of the 
glycerol backbone. The corresponding headgroup for each sub-class of phospholipids is denoted 
in red circles. Hydroxyl and oxygen moieties are denoted in red text. This figure was modified 
from reference  [5] 
 
Phospholipids are the primary lipid components of biomembranes. Phospholipids have a 
glycerol backbone that is esterified with acyl chains at the sn-1 and sn-2 positions and have a head 
group attached at the sn-3 position (Fig 1.1). Phospholipids are categorized into sub-classes 
Figure 1. 2. Types of phospholipids. 
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depending on the type of the head group that is attached (Fig 1.2). The next major lipid class is the 
sphingolipids. Sphingolipids are based on a ceramide backbone to which an acyl chain is attached 
via an amide linkage. This class of membrane lipid accounts for almost 40% of the total inositol-
containing lipids in the yeast [7].  Sphingolipids in yeast are classified into three major sub-classes: 
inositol-P-ceramide (IPC), mannose-inositol-P-ceramide (MIPC) and mannose-(inositol-P)2-
ceramide (M(IP)2C) [2, 8]. The third major lipid class is the sterols. Ergosterol, the primary yeast 
sterol, is a four-ring structure with a hydrophilic hydroxyl group and an acyl side chain. The main 
structural difference in ergosterol with respect to cholesterol is that it has an extra carbon atom and 
one hydrogen in the side chain being replaced by methyl group [6]. Sterols, like ergosterol, are 
crucial in maintaining cell viability and membrane integrity in eukaryotic cells [6].  
These major lipid classes along with membrane proteins form numerous specialized 
biomembranes such as the plasma membrane, the mitochondrial membrane, the endoplasmic 
reticulum, the Golgi apparatus membrane, the nuclear membrane, and the vacuolar and 
peroxisomal membranes. These membranes are involved in specialized functions including 
compartmentalization, metabolic energy generation, protein and lipid synthesis, and protection of 
genetic material.  
 
1.3. Overview of phospholipid metabolism in yeast 
 
The typical phospholipid composition of the plasma membrane (PM) is 
phosphatidylcholine (PC, 38%), phosphatidylethanolamine (PE, 30%), phosphatidylserine (PS, 
4%), phosphatidylinositol (PI, 16%), cardiolipin (CL, 5%) and other minor phospholipids (7%) 
[6]. The other minor phospholipids include phosphatidic acid (PA), cytidine diphospho-
diacylglycerol (CDP-DAG), phosphatidyldimethylethanolamine (PDME), 
phosphatidylmonomethylethanolamine (PMME), triacylglycerol (TAG) and diacylglycerol (DAG) 
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[6]. The lysophospholipids have a single fatty acid chain and make up a minor amount of the total 
lipid composition [6, 9]. 
 
 
The enzymes catalyzing each step are indicated in italics. The enzymes regulated by the Henry 
Regulatory Circuit are in blue. Abbreviation: G3P, glycerol-3-phosphate; LPA, lysophosphatidic 
acid; DHAP, dihydroxyacetone phosphate; acyl-DHAP, acyl dihydroxyacetone phosphate; PA, 
phosphatidic acid; TAG, triacylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; PE, 
phosphatidylethanolamine; PMME, phosphatidylmonomethylethanolamine; PMDE, phosphatidyl 
dimethylethanolamine; PC, phosphatidylcholine; Cho, choline; Cho-P, choline phosphate; Etn, 
ethanolamine; Etn-P, ethanolamine phosphate; PIP, phosphorylated phosphatidylinositol 
phospholipids; GPC, glycerophosphocholine; GPI, glycerophosphoinositol This figure was 
obtained from reference [5].   
 
The pathways for phospholipid synthesis are interconnected with PA being the central lipid 
intermediate for the syntheses of other phospholipids [5]. PA is synthesized via the stepwise 
acylation of glycerol-3-phosphate (G3P) to lysophosphatidic acid (LPA) by the glycerol-3-
Figure 1. 3. Pathways for phospholipid synthesis in yeast. 
 6 
 
phosphate acyltransferases, Sct1 and Gpt2. LPA is then subsequently converted to PA by LPA 
acyltransferases, Slc1 and Ale1 [5, 6, 10-12]. PA is partitioned into making CDP-DAG and DAG 
by the enzymatic action of Cds1 and Pah1, respectively (Fig 1.3). CDP-DAG is used in the 
production of PI, CL, PG, and PS. DAG is used for CDP-choline and CDP-ethanolamine pathways 
for PC and PE synthesis, respectively (Fig 1.3). Along with the synthesis of phospholipids, DAG 
also enters the lipid storage pathway for TAG production. The detailed discussion of DAG and 
CDP-DAG utilization are reviewed below. 
Synthesis and turnover of TAG: The PA phosphatase, Pah1 catalyzes the conversion of PA 
to DAG. DAG is a crucial precursor molecule in the synthesis of  TAG [13]. Dga1 and Lro1 are 
acyl-CoA-dependent and phospholipid-dependent acyltransferases, respectively, that catalyzes the 
conversion of DAG to TAG [13]. In a nutrient deprivation stage of the cell cycle, such as the 
stationary phase, TAG is mobilized to produce fatty acids that are important for the synthesis of 
phospholipids and sphingolipids [14]. The TAG lipases such as Tgl1, Tgl3, Tgl4, and Tg15 
catalyzes the hydrolysis of TAG [15]. 
Utilization of CDP-DAG for PI, CL, and PS synthesis: CDP-DAG is partitioned into the 
production of PI, CL, and PS. Inositol is an essential phospholipid precursor for PI synthesis. 
Inositol is produced in the cell by converting glucose-6-phosphate to inositol by the sequential 
enzymatic action of Ino1 and Inm1 [16]. Further, Pis1 catalyzes the synthesis of PI by utilizing 
CDP-DAG and inositol. Cho1, a PS synthase, catalyzes the conversion of CDP-DAG to PS [17]. 
PS can be decarboxylated to PE by two PS decarboxylases, Psd1 and Psd2 [5]. For cardiolipin (CL) 
production, CDP-DAG combines with G3P to synthesize phosphatidylglycerol phosphate (PGP). 
PGP undergoes dephosphorylation to PG by a phosphatase, Gep4 [18]. Finally, PG and CDP-DAG 
is used in making CL by the catalytic action of CL synthase, Crd1 [18].  
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Utilization of DAG for PE synthesis: PE is produced via two major routes: the PS 
decarboxylation (as described above) and CDP-ethanolamine pathways. In the CDP-ethanolamine 
pathway, ethanolamine is phosphorylated by Eki1 kinase to ethanolamine-phosphate, which is 
subsequently activated to CDP-ethanolamine by a cytidyltransferase, Ect1 [5]. Eventually, Ept1 
catalyzes the final conversion of CDP-ethanolamine and DAG to PE [5]. 
 
 
Utilization of DAG for PC synthesis: Like PE synthesis, PC can be made via two major 
pathways, PE methylation and CDP-choline or Kennedy pathway. In the PE methylation pathway, 
PE undergoes three sequential methylation reactions in the ER by two phospholipid 
methyltransferase enzymes, Cho2 and Opi3. Cho2 catalyzes the conversion of PE to 
phosphatidylmonomethylethanolamine (PMME), while Opi3 catalyzes the conversion of PMME 
to phosphatidyldimethylethanolamine (PDME) and PDME to PE [5, 19]. In the CDP-choline or 
Kennedy pathway, exogenous choline can be transported into the cell by the Hnm1 transporter 
[17]. The intracellular choline undergoes phosphorylation to choline-P in the cytosol by Cki1. 
Choline-P is then activated to CDP-choline by a cytidyltransferase enzyme, Pct1 [5]. Finally, a 
choline phosphotransferase, Cpt1, catalyzes the conversion of CDP-choline and DAG to form PC 
[5].  
As mentioned previously, supplementation of inositol and choline have a significant impact 
on the lipid profile in yeast. Susan A. Henry and colleagues have characterized the effects of 
inositol and choline supplementation on the lipid profile. Inositol decreases the level of PA, that 
in-turn results in increased levels of PI (Fig 1.4).  The Henry regulatory circuit is the mechanism 
by which inositol controls the levels of PA and PI in the cell (further discussion is included in 
section 1.4). 
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A. Phospholipid profile with and without inositol supplementation. B. NL profile with and without 
supplementation. Grey bars: medium lacking both inositol and choline, Stripped bars: medium 
containing Inositol, white bars: medium containing choline, black bars: medium containing 
inositol and choline. Abbreviations: SE, steryl esters; FFA, free fatty acids; FS, free sterols.  This 
figure was obtained from reference [20]. 
 
The metabolism of all the major phospholipids described so far can be regulated at various 
stages in a pathway. Inositol is involved in the regulation of several genes that are involved in 
phospholipid metabolism. Many of these genes contain an UASINO element region in their 
promoters, which is involved in the regulation of the gene through the Henry regulatory circuit [5].  
 
 
1.4. Regulation of UASINO-containing genes by the Henry regulatory circuit and other 
regulatory factors  
 
Inositol availability has far-reaching transcriptional and physiological effects in yeast. As 
discussed before, inositol is vital for PI biosynthesis. Inositol can either be transported into the cell 
or can be produced by conversion of glucose-6-phosphate [20]. PI is a precursor for several 
molecules including the phosphoinositides, polyphosphates, inositol sphingolipids, and GPI 
Figure 1. 4. Effect of inositol and choline on phospholipid and neutral lipids (NL) profile 
in WT yeast cell. 
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anchors [21]. These inositol containing molecules play an essential role in cell signaling and as 
structural components of the cell membrane [21].   
 
 
In the absence of inositol, PI levels are low and PA levels are high. The high levels of PA allow 
Opi1 to interact with the PA and Scs2, allowing the transcription of UASino-containing gene by the 
Ino2-Ino4 complex. Upon supplementation of inositol to the medium, PI level increases, which 
releases the Opi1 and allows its translocation to the nucleus. Opi1 along with Sin3 results in 
transcription repression of UASino-containing gene. This figure was obtained from reference [5].  
 
Henry regulatory circuit: Most genes responsive to inositol have been found to be 
regulated by the Henry regulatory circuit involving transcription factors Ino2, Ino4, and Opi1. This 
complex mechanism involves the modulation of PA levels at the ER membrane surface, which in 
turn impacts the transit of the Opi1 repressor protein into the nucleus (Fig 1.5.) [5]. Cells grown 
in the absence of inositol displays low levels of PI and high levels of PA. Under this limiting 
Figure 1. 5. Model for Henry regulatory circuit for regulation of UASino-containing 
genes. 
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condition, the repressor Opi1 interacts with Scs2 and PA at the cytoplasmic face of the ER. The 
heterodimer Ino4-Ino2 complex bound to a UASINO consensus sequence-containing gene continues 
to activate transcription [22]. Conversely, in the presence of inositol, PI levels increase, and PA 
levels drop, releasing Opi1. Opi1 migrates to the nucleus and binds the heterodimer Ino4-Ino2 
bound to the UASINO consensus sequence-containing gene, resulting in repression [5, 22].  
 
Zinc mediated gene regulation: Zinc is an important nutrient required for growth of 
S.  cerevisiae. It is a crucial cofactor for synthesis of numerous metabolic enzymes, chaperones, 
lipid-binding proteins, and transcription factors.  The regulation of a gene by zinc involves the 
interaction of Zap1, a zinc-inducible transcriptional activator with a zinc response element 
(UASzre)-containing gene [5]. This mechanism of regulation requires inositol deprivation in the 
medium that increases intracellular level of PA in the cell. Conversely, reduction in the cytosolic 
levels of zinc induces PI synthase to increase synthesis of PI. This increased level of PI 
consecutively regulates gene via the Henry regulatory circuit [5, 23].  
Regulation via phosphorylation: The enzymes involved in lipid metabolism can also be 
regulated by post-translational modification through phosphorylation. There are several kinases 
such as protein kinase A and C, cyclic-dependent kinase and AMP-activated protein kinase that 
are known to regulate enzymes involved in phospholipid metabolism [5].  
Along with these major regulatory mechanisms, mRNA degradation also contribute in 
regulating genes involved in lipid metabolism [5]. The next two sections discuss the different 
classes of lipid-modifying enzymes that are involved in the metabolism of lipids. 
 
1.5. Role of phospholipases, permeases, and glycerophosphodiesterases in phospholipid 
metabolism 
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Lipid homeostasis can be achieved by regulating synthesis, transport, breakdown and 
remodeling of membrane lipids [6]. Phospholipases, permeases and glycerophosphodiesterases are 
responsible for production, transportation and metabolism of the glycerophosphodiesters (GPXs) 
in the cell.  
Phospholipases are enzymes that hydrolyze phospholipids to various metabolites. These 
free metabolites are involved in vital cellular processes such as signaling, nutrient acquisition, 
remodeling and membrane homeostasis [24]. Phospholipases are classified into A, B, C, and D 
types, depending on the nature of the hydrolysis action carried out by these enzymes. The B-type 
phospholipases can perform hydrolysis at both sn-1 and sn-2 position of phospholipid to produce 
glycerophosphodiesters (GPXs) and free fatty acids (Fig 1. 6. B, C). Yeast has four genes PLB1, 
PLB2, PLB3 and NTE1 that encode B-type phospholipase enzymes.  Plb1 is primarily responsible 
for deacylation of PC to GPC [25] [26]. Plb2 is responsible for deacylation of exogenous 
phospholipids [27]. Plb3 primarily acts on PI and PS to produce GPI and GPS [27], respectively, 
while Nte1 deacylates PC to GPC at the ER [28].  
GPXs are hydrophilic molecules that are unable to pass the PM without the aid of 
permeases. The permease Git1facilitates the uptake and transport of GPI and GPC into the cell 
(Fig 1. 6. A). Git1 is phosphate regulated, i.e., low levels of phosphate in the medium increases 
the expression of GIT1, and high levels of phosphate decreases the expression [29, 30]. 
Gde1 is a glycerophosphodiesterase that is found in S. cerevisiae, Candida albicans, 
mammals and plants. Gde1 hydrolyzes GPC to G3P and free choline (Fig 1.6. D) [31, 32]. Like 
Git1, Gde1 is regulated by the levels of phosphate in the medium. The free choline that is produced 
via the action of Gde1 is recycled through the CDP-choline pathway for PC synthesis.   
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A. Schematic representation of the enzymes involved in the metabolism of GPC in the cell. Lipases 
are in red; phosphodiesterase is in green and permease in blue. B. Deacylation of PC to GPC by 
B-type phospholipase. C. Deacylation of LPC to GPC by PLB. D. Hydrolysis of GPC by 
phosphodiesterase, Gde1. Structures were obtained from LIPID maps database 
(https://www.lipidmaps.org/) to make this figure. 
 
1.6. Classification of acyltransferases and transacylases involved in the metabolism of 
phospholipid 
 
Acyltransferases are a group of enzymes founds in fungi, plants and animals [33]. They 
catalyze the transfer of an acyl chain from an acyl donor to an acyl acceptor [33], and in the most 
cases, acyltransferases utilize acyl-Coenzyme A as an acyl donor. Acyltransferases are broadly 
classified into glycerophosphate acyltransferase (GPATs), dihydroxyacetonephosphate 
acyltransferases (DHAPATs), acylglycerophosphate acyltransferases (AGPATs) and membrane-
bound O-acyltransferases (MBOATs).  
Figure 1. 6. Role of phospholipases, permeases, and glycerophosphodiesterase in the 
metabolism of GPC. 
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The GPATs catalyze the first step in de novo synthesis of PA (Fig 1.7) i.e., the conversion 
of G3P to LPA and the DHAPATs catalyze the conversion of DHAP to form 1-acyl-DHAP (Fig 
1.7) [33].  S. cerevisiae has two genes, SCT1/ GAT2 and GPT2/ GAT1, that encode enzymes with 
dual substrate specificity [34], i.e., these enzymes can use both G3P and DHAP molecules as an 
acyl acceptor (Fig 1.6). The acyltransferases also show different degrees of specificity towards the 
acyl chains they incorporate in the acceptor molecule. Palmitic acid (C16:0), palmitoleic acid 
(C16:1), stearic acid (C18:0) and oleic acid (C 18:1) are the major FAs that are esterified on sn-1 
and sn-2 positions of the glycerol backbone to produce phospholipids [5, 35]. For example, Sct1 
prefers incorporation of palmitate (16:0) as an acyl chain, while Gpt2 prefers incorporation of 
oleate (18:1) at the sn-1 position of either G3P or DHAP [34, 36]. 
AGPAT catalyzes the second step in de novo synthesis of PA (Fig 1.7), i.e. the conversion 
of LPA to PA by incorporating an acyl chain at an sn-2 position of an LPA molecule. In yeast, 
SLC1 has been characterized as the AGPAT having the highest activity towards LPA [33, 37]. 
Some acyltransferases are associated with membranes and belong to membrane-bound O-
acyltransferases that prefer incorporation of a monounsaturated acyl chain (C16:1 or C18:1) at an 
sn-2 of LPL [38]. In yeast, ALE1 (Alternative published names: SCL4, LPT1, and LCA1) has been 
characterized to have LPL acyltransferase activity, including, LPC and LPE acyltransferase 
activity (Fig 1.8.) [37-42]. Conversely, Cst26/Psi1 that has been characterized as an 
acyltransferase that prefers incorporation of a saturated acyl chain (18:0) at the sn-1 position of 
LPI to produce PI [43]. 
 14 
 
    
A. Schematic representation of DHAP acyltransferase and G3P acyltransferases in yeast. B. 
Illustration of the substrate specificity for different acyltransferases. Abbreviations: Gro-3-P, 
glycerol-3-phosphate; LPA, lysophosphatidic acid; DHAP, Dihydroxyacetone phosphate; acyl-
DHAP, acyl dihydroxyacetone phosphate; PA, phosphatidic acid; TAG, triacylglycerol. This 
figure is obtained from reference [34]. 
Lysophosphatidylcholine acyltransferases (LPLAT), ALE1 (Alternative published names: SCL4, 
LPT1, and LCA1), utilizes monounsaturated acyl-CoA to acylate LPC to PC. The structures were 
obtained from the LIPID MAPS database (https://www.lipidmaps.org/).  
Figure 1.7. Acyltransferases in yeast. 
Figure 1. 8. LPLAT acyltransferases in yeast. 
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Cardiolipin (CL) is a specialized phospholipid containing four acyl chains. CL is produced 
and localized to the inner membrane of the mitochondria [6, 44]. Defects in CL remodeling due to 
the protein Tafazzin are seen associated with the Barth syndrome in mammals [45]. Taz1, the yeast 
homolog of Tafazzin, is a transacylase that is involved in the remodeling of CL in yeast [18]. Taz1 
converts monolysocardiolipid (MLCL) to CL, using phospholipid as an acyl donor and MLCL as 
the substrate [38]. Lro1 is another transacylase that converts substrates PE or PC and DAG to LPE 
or LPC and TAG, respectively [46-48]. 
 
 
 
GPC1 encodes a novel glycerophosphocholine acyltransferase acylating GPC to LPC. The 
structures were obtained from the LIPID MAPS database (https://www.lipidmaps.org/). 
 
 
Figure 1. 9. GPCAT acyltransferases in yeast 
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GPC can either be transported into the cell or can be produced through PC deacylation by PLBs. 
GPC can be reacylated to LPC by Gpc1, and LPC can then be subsequently converted to PC by 
Ale1. The PC-DRP pathway is denoted in red. The methylation and Kennedy pathway are denoted 
in blue and green respectively. Abbreviation: GPC, glycerophosphocholine; LPC, 
lysophosphatidylcholine; PDME, phoshodimethylethanolamine; PMME, 
phosphomonomethylethanolamine. 
 
1.7. A novel pathway for PC biosynthesis in bacterium, yeast and plants 
 
Glycerophosphocholine acyltransferase (GPCAT) activity was first identified in yeast in 
2008 by Stalberg and colleagues [49]. The activity was later identified in Xanthomonas campestris 
and plants [49-51]. Stalberg and colleagues attempted to identify the GPCAT encoding gene by 
performing genetic and biochemical analysis on the known acyltransferases, transacylases and 
lipases [49]. Still, the gene that encoded the activity remained undiscovered. Our collaborators, 
Figure 1. 10. GPC1 defines a novel PC deacylation/reacylation pathway (PC-DRP) for 
PC biosynthesis. 
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Ida Lager and colleagues, identified YGR149w as the ORF encoding the GPCAT activity by 
screening cell extracts derived from the S. cerevisiae knock-out collection. Using in vivo metabolic 
labeling studies, we have identified the role of YGR149w in a novel pathway for PC biosynthesis 
in S. cerevisiae. The gene was named GPC1. The details of these studies are in Chapter two. I have 
further characterized the physiological function and regulatory features of this pathway. The 
details of these studies are in Chapter three.  
The novel pathway for PC biosynthesis begins with the utilization of 
glycerophosphocholine (GPC). GPC can either be produced by the complete deacylation of PC by 
the action of the PLBs, Plb1 or Nte1 (Fig 1.10), or it can be internalized into the cell from the 
medium through Git1 (Fig 1.6) [26, 28]. The endogenous GPC can be acylated to 
lysophosphatidylcholine (LPC) by the GPC acyltransferase, Gpc1 (Fig 1.9) [52]. Subsequently, 
LPC can be converted to PC by the LPCAT, Ale1 [39]. 
Gpc1 is predicted to be an integral membrane protein with eight transmembrane spanning 
segments [53], and has a molecular weight of 52 kDa [52]. The predicted topology model of Gpc1 
is shown in Fig 1.11. There are five post-translation modification sites present on Gpc1 that was 
identified by genome wide MS analysis studies (SGD; http://www.yeastgenome.org). Four out of 
five of these modifications are phosphorylations produced at amino acid (aa) positions 76, 78, 403 
and 406, and the final modification is ubiquitination at position 86 (Fig. 1.11). These modifications 
suggest that both N and C-terminal of the Gpc1 are in the cytoplasmic region. Gpc1 belongs to a 
new family of acyltransferases having one domain with no known function (DUF2838) [52]. It 
lacks the know lipases or acyl binding motifs present in other studied acyltransferases and 
transacylases [49, 52]. Analysis of the GPC1 homologs reveals a wide distribution in eukaryotes 
including fungi, animal, plants, algae, and most protist clades. No significant homologs were 
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present in animal subclades or prokaryotes [52]. The homologs of GPC1 were found using 
sequence similarity in three plant species Arabidopsis thaliana, Brassica napus, and Ricinus 
communis (Chapter two). The next two sections (1.8. and 1.9.) of the introduction focus on the 
importance of the acyl chain remodeling that impacts physio-chemical properties of biomembranes. 
 
Gpc1 is 432 amino acid long containing five sites for post-translational modification present at N 
and C-terminal of the Gpc1 that are predicted to be in the cytoplasmic region. The model is 
generated using Protter- open source tool (http://wlab.ethz.ch/protter/start/). Phosphorylation sites 
are in solid red diamond and ubiquitination site in pink diamond. The region marked by pink circles 
is a domain of unknow function (DUF2838).  
 
1.8. Acyl chain remodeling affects the phospholipid molecular species that impact physical 
properties of the membrane  
Phospholipids are classified depending upon the nature of the polar head group at the sn-3 
position of the glycerol backbone. However, within each of these classes, phospholipids are 
present in multiple molecular species depending upon the length and saturation of the acyl chains 
esterified to the glycerol backbone. The ensemble of these phospholipids with variations in the 
Figure 1.11. Predicted Gpc1 topology model. 
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acyl chain composition can affect the physicochemical properties of the membrane. Acyl chain 
remodeling of phospholipid is a post-synthetic process where one or both the acyl chains undergo 
exchanges. For the reason of simplicity, I am describing the known evidence of the PC remodeling, 
but remodeling has been studied and shown to occur in other phospholipids [10, 18, 38, 54].  
Major evidence of PC remodeling: Remodeling was first reported as the Land’s cycle in 
1960. This two-step process involves deacylation of PC to LPC by the action of phospholipase A 
(PLA) and subsequent reacylation to PC [55].  Yamada and colleagues were the next to 
demonstrate an acyl-CoA dependent acyltransferase activity for both isoforms of LPC in vitro in 
rats [56]. The phospholipid profile in yeast is simple when compared to higher eukaryotes. This 
made Wagner and colleagues investigate remodeling in yeast. They used a radiolabeling approach, 
where 14C-palmitate and 3H-oleate FAs were supplied to the medium. They reported selective 
incorporation of these radiolabeled FAs into both sn-1 and sn-2 position of PC within 2 minutes 
of uptake [57]. Tanaka and colleagues showed PC remodeling by supplementing short eight carbon 
chain (methyl-13C)3 in medium. The results indicated the exchange of these radiolabeled short acyl 
chains with the natural C16 and C18 acyl chains [58]. Recently, PC remodeling was shown using 
deuterium-labeled (methyl-D3)-methionine followed by ESI-MS/ MS analysis to examine the PC 
molecular species [10, 59]. The results revealed an increase in monounsaturated PC species (32:1, 
34:1) at the expense of diunsaturated PC species (32:2, 34:2) [60]. This evidence suggests that 
remodeling leads to an alteration in phospholipid molecular species which could potentially affect 
membrane properties. The following are key attributes of the membrane that could be impacted by 
the acyl chain remodeling. 
Membrane fluidity: Lipid bilayer exists in two phases, the liquid crystalline phase and gel 
phase [61]. The liquid crystalline phase is a fluidic and disordered state, while the gel phase is a 
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rigid and ordered state. The length of the acyl chain and the introduction of a cis-double bond are 
the significant characteristics that affect the membrane fluidity (Fig 1.12) [61]. Fluidity is 
maintained at an altered temperature by modifying both the length and saturation of acyl chains. 
The classes and sn-isomers of phospholipid species play an essential role in achieving the desired 
membrane fluidity. For instance, PE molecular species have a smaller head group as compared to 
the PC molecular species, that allows for tighter packing of PE. The phospholipid molecular 
species with a saturated or longer acyl chain at the sn-1 position have a lower melting temperature 
as compared to phospholipid molecular species with similar acyl chain at the sn-2 position [61, 62] 
Membrane thickness: Membrane thickness is influenced by the length and saturation in the 
acyl chains of the lipids (Fig 1.12). The unsaturated lipids decrease the membrane thickness when 
compared to the corresponding saturated lipids. Whereas, an increase in the length of the acyl 
chain would result in an increase in membrane thickness [61, 62].  
 
Membrane intrinsic curvature: Upon hydration phospholipids spontaneously assemble into 
bilayers, but few lipids prefer to assemble into a non-bilayer phase. This difference in the behavior 
depends upon the “shape structure” concept [61, 62]. The ratio of the cross-section area of head 
group to that of the acyl chains determines the phase preferred by the lipid. If the cross-section 
areas of the head group to that of the acyl chains is similar (example PC), then the molecule would 
possess a cylindrical shape and would favor forming a bilayer (Fig 1.12).  Lipids such as LPC have 
a larger head group cross-section area compared to its acyl chain. This makes LPC prefer forming 
micelles in an aqueous environment. These lipids would give a positive intrinsic curvature to the 
membrane. Lipids such as PE and PA, have a smaller head group cross-section area and a larger 
acyl chain cross-section area, which gives them the inverted hexagonal shape (Fig 1.12). These 
lipids would contribute to a negative curvature in the membrane [61, 62].  
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Fluidity increases with short and unsaturated fatty acid. The kinks caused by double bond lower 
the packing density and inhibit the transition to a solid gel phase. The length of the acyl chain and 
sterol packaging influence the thickness of a membrane. Lipid shape decides the curvature of the 
membrane. This figure was obtained from reference [61].  
 
1.9. Significance of phospholipid remodeling for physiological functions in the higher 
eukaryotes 
Phospholipid remodeling is important for preserving the differences in the acyl chain 
content present in the secretory pathway [63]. These differences are believed to be critical in 
organelle functioning and identity [10]. Organelles of the secretory pathways show a steady 
increase in saturated phospholipids at an expense of monounsaturated phospholipids as the 
location of organelles moves closer to plasma membrane. Alveolar type-II cells produce and 
Figure 1. 12. Acyl chain composition affects the physical properties of membrane. 
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secrete pulmonary surfactant complex that primarily contains dipalmitoylphosphatidylcholine 
(DPPC). DPPC was shown to be synthesized by a lysophosphatidylcholine acyltransferase 
(LPCAT) through PC remodeling [64]. Defects in LPCAT activity are known to result in diseases 
states. The hepatic inflammation of liver results by an increase in the levels of LPC in a Lpcat3 
knockout mouse [65]. Lpact3 was also shown to be vital for incorporation of arachidonic acid 
(C20: 4) into PC for TAG secretion in the intestine and liver [66].  
 
1.10. Membrane lipids in Bacteria and Archaea  
Bacterial species exhibit a vast degree of diversity in their membrane lipid composition. 
This diversity is influenced by the harsh environmental factors to which these organisms are 
exposed. Most bacterial membranes contain phospholipids, such as PE, PG, CL, Lysine-PG (LPG), 
PI, PA, and PS [67]. Bacteria can additionally produce phosphate-free lipids such as ornithine 
lipids (OLs), sulfolipids, diacylglyceryl-N,N,N trimethylhomoserine (DGTS), glycolipids (GLs), 
DAG, hopanoids (HOPs) and others [67]. Escherichia coli (E. coli) is the most common bacterial 
model organism used for studying the membrane lipids. The three major phospholipid classes in 
E. coli are PE (accounting for 75% of total membrane lipids), PG (accounting for 20% of total 
membrane lipids) and CL [67]. Bacterial species such as actinomycetes and δ-proteobacteria are 
known to produce PI, which is typically a eukaryotic lipid [67]. Some of the gram-positive 
bacterial species can add amino acids like lysine, alanine or arginine to PG to form lysine-PG, 
alanine-PG and, arginyl-PG, respectively. Bacteria from Cytophaga Flavobacterium-Bacteroides 
(CFB) group and actinomycetes are known to produce phosphate free lipids, OLs [67]. Eukaryotes 
and archaea lack OLs [67]. HOPs are present in some groups of bacteria such as cyanobacteria, 
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methylotrophic bacteria, actinomycetes, β-proteobacteria and δ-proteobacteria [67]. This lipid 
class is required for improving the stability and permeability of the bacterial membrane [67]. 
Archaea have a distinctive membrane lipid composition as compared to bacteria or 
eukaryotes. In bacteria and eukaryote, the fatty acid side chains present in phospholipid are ester-
linked to the glycerol backbone. However, in archaea the fatty acid chains are ether-linked to the 
glycerol backbone [68]. Archaeal membrane lipids have a characteristic feature of containing 
isoprenoid moieties in its fatty acid chains [68]. The polar head group that classifies the 
phospholipids are similar to those found in bacteria and eukaryotes. The membrane lipids in 
archaea show several variations in the length of the isoprenoid chains, cyclization of the isoprenoid 
chains and numerous other adaptations [68]. However, the synthesis and regulation of these lipids 
in archaea are not well characterized [68].  
 
1.11. Summary of background and significance 
GPCAT activity was previously identified in bacteria, yeast, and plants, but the genes 
encoding the activities had remained unknown [49-51]. Our collaborators, Ida Lager and 
colleagues from the Swedish University of Agricultural Sciences, identified the GPCAT-encoding 
gene using S. cerevisiae as the model organism. The objective of this dissertation was to perform 
a thorough examination of the gene product to determine its role in PC metabolism in vivo in S. 
cerevisiae. 
S. cerevisiae has two major pathways for bulk synthesis of PC. My research focused on 
examining the significance of having a third alternative route for PC biosynthesis. The central 
hypothesis was that the GPC1 was nonessential for the bulk synthesis but was vital for the post-
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synthetic acyl chain remodeling of PC that could have a potential effect on the physical properties 
of the membrane.  
The specific objectives of the project were: 1) Examining the in vivo role of Gpc1 in PC 
biosynthesis, 2) Investigating the role of GPC1 in post-synthetic PC remodeling and 3) identifying 
the regulatory mechanisms controlling its expression. These objectives are discussed in detail in 
Chapter two and three, respectively. These studies have defined a novel PC deacylation/reacylation 
remodeling pathway (PC-DRP) that has increased our understanding of PC metabolism.  
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2.1. ABSTRACT 
Glycero-3-phosphocholine (GPC), the product of the complete deacylation of 
phosphatidylcholine (PC), was long thought to not be a substrate for reacylation. However, it was 
recently shown that cell-free extracts from yeast and plants could acylate GPC with acyl groups 
from acyl-CoA. By screening enzyme activities of extracts derived from a yeast knock-out 
collection, we were able to identify and clone the yeast gene (GPC1) encoding the enzyme, named 
glycerophosphocholine acyltransferase (GPCAT). By homology search we also identified and 
cloned GPCAT genes from three plant species. All enzymes utilize acyl-CoA to acylate GPC 
forming LPC, and they show broad acyl specificities in both yeast and plants. In addition to acyl-
CoA, GPCAT efficiently utilizes LPC and lyso-phosphatidylethanolamine as acyl donors in the 
acylation of GPC. GPCAT homologues were found in the major eukaryotic organism groups but 
not in prokaryotes or chordates. The enzyme forms its own protein family and does not contain 
any of the acyl binding or lipase motifs that are present in other studied acyltransferases and 
transacylases.  In vivo labeling studies confirm a role for Gpc1p in PC biosynthesis in yeast. It is 
postulated that GPCATs contribute to the maintenance of PC homeostasis and have specific 
functions in acyl editing of PC, e.g. in transferring acyl groups modified at sn-2 position of PC to 
the sn-1 position of this molecule in plant cells.  
 
2.2. Introduction 
Phosphatidylcholine (PC) is the most abundant membrane lipid in all non-photosynthetic 
eukaryotes and in extraplastidic membranes in photosynthetic eukaryotes. It also has a central role 
in membrane homeostasis through the remodeling of its acyl groups in response to changing 
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environmental and metabolic conditions [69]. In plants, PC acyl chain modifications produce 
multiple polyunsaturated and unusual fatty acids which are delivered from PC, through various 
pathways, to other lipids, including the storage lipid triacylglycerol [70]. In yeast and other 
eukaryotic cells, the established pathways for PC biosynthesis are the CDP-choline pathway and 
the phosphatidylethanolamine (PE) methylation pathways. Once formed, the common pathway for 
PC turnover is the hydrolysis of acyl groups by phospholipases of the A or B type. Hydrolysis by 
an A type enzyme results in free fatty acid and lysophosphatidylcholine (LPC). The remaining 
acyl group of LPC can be hydrolysed by phospholipases of the A or B type to yield free fatty acids 
and glycerol-3-phosphocholine (GPC).  
 
Yeast gene products are indicated. Generic terms for some enzymatic steps that apply to yeast and 
plants are shown in parenthesis: GPCAT, glycerophosphocholine acyltransferase; LPCAT, 
lysophosphatidylcholine acyltransferase.  LPC, lysophosphatidylcholine; PC, phosphatidylcholine; 
Figure 2. 1. Schematic outline of glycerophosphocholine (GPC) metabolism in yeast. 
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G3P, glycerol-3-phosphate. For simplicity sake, the PE methylation and Kennedy pathways for 
PC biosynthesis are not shown. 
 
 
 
GPC is known to be catabolized to free choline and glycerol-3-phosphate (G3P) [31, 71, 
72] and the resulting choline is used in the de novo synthesis of PC via the CDP-choline pathway 
[73]. Importantly, direct acylation of GPC by an acyl-CoA-dependent activity was recently 
demonstrated in Saccharomyces cerevisiae cell free extracts and microsomal preparations [49]. 
The putative enzyme carrying out the acylation of GPC was named GPC acyltransferase (GPCAT) 
(see Fig. 2. 1). Recently, GPCAT activities were also demonstrated in microsomal preparations 
from developing seeds from different plant species, as well as in Arabidopsis roots and shoots [50]. 
To a varying extent, the different microsomal preparations incorporated radioactive [14C]GPC into 
both LPC and PC even in the absence of acyl-CoA [50].  
In this work we screened a yeast deletion library to identify the yeast gene encoding 
GPCAT, which we have termed GPC1. By homology search we have also identified GPCAT 
encoding genes from plant species. In addition, we report that not only can GPCAT enzymes utilize 
acyl-CoA to acylate GPC but can also catalyze the transacylation of acyl groups from LPC to GPC. 
The latter reaction explains the earlier reported incorporation of GPC into lipids in the absence of 
added acyl-CoA in assays with microsomal preparation from developing oil seeds [50]. The 
GPCAT does not show any significant homology to other known acyl transferases and constitutes 
an enzyme family on its own with homologues represented in major eukaryotic organism groups 
but absent in prokaryotes.  
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2.3. Results and Discussion 
2.3.1. Identification of the yeast GPCAT-encoding gene 
 
A subset of the yeast knock-out collection was used to screen for the GPCAT-encoding 
gene. Only strains carrying deletions in genes with no known or putative function and with a size 
of at least 500bp were included. This group contained approximately 600 strains. Yeast extracts 
from the deletion strains were incubated with [14C]choline labelled GPC, acyl-CoA and, as a 
control, [14C]G3P; the lipids were separated by thin layer chromatography and visualized on an 
Instant Imager electronic autoradiograph.  
 
 
Figure 2. 2. Identification of ScGPCAT (GPC1). 
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Yeast extracts of strains from the yeast deletion collection were incubated with [14C]GPC and 18:1-
CoA. [14C]G3P was added to the incubation as an internal control of enzymatic activities. A. The 
enzyme reactions in yeast from the substrates [14C]GPC and [14C]G3P. The yeast acylating 
enzymes are indicated in the figure. B. An autoradiogram of the screening on thin layer 
chromatography plates showing the deletion strain lacking GPCAT activity (within the hatched 
square). C. Complementation of YGR149W (GPC1) in the gpc1∆ deletion strain. Empty vector as 
well as the deletion strain (gpc1∆) are also included. Irrelevant lanes from the plate have been 
removed from the picture (marked by a vertical line). D. Western blot of Gpc1p. Wild type strain 
bearing empty vector (EV) or a plasmid (GPC1-V5) harboring GPC1 under the control of the 
galactose-inducible GAL1 promoter and containing a C-terminal V5 epitope. Cells were grown on 
either glucose or galactose. Equivalent amounts of protein (75 g) were loaded onto each lane. 
Anti Gpc1p-V5 primary antibody and goat anti-mouse secondary antibody were employed. Blot 
visualized using an Odyssey FC imaging system. Glucose-6-phosphate dehydrogenase (G6PD) 
was used as the loading control.  
 
In the reaction, the putative GPCAT utilized acyl-CoA to convert GPC to LPC, which was 
further acylated to PC by the endogenous Ale1p. G3P was added to the assay as an internal control 
to validate the quality of the yeast extract and to provide a ratio of G3P to GPC acylation activity 
for detecting decreased GPCAT activity. G3P is acylated to lysophosphatidic acid (LPA) by the 
enzymes Gat1p and Gat2p and the formed LPA is converted to phosphatidic acid (PA) by Slc1p 
(Fig. 2.2.A). We identified a deletion strain lacking GPCAT activity, but exhibiting G3P acylation 
after approximately 200 screened strains, and the remaining strains were not screened. (Fig. 2.2.B). 
The identified strain bears a deletion in ORF YGR149W, here named GPC1, which is annotated as 
a putative protein of unknown function in the Saccharomyces Genome Database. The gene was 
amplified, cloned into a PYES-based yeast vector, and expressed in the identified deletion strain. 
As can be seen in Fig. 2. 2C, GPC1 complemented the deletion strain. GPC1 contains only one 
defined domain of no known function (DUF2838) and has no known acyl binding domains. The 
S. cerevisiae GPCAT (ScGPCAT) or Gpc1p is a protein of 52 kDa that is predicted to be an integral 
membrane protein with 8 transmembrane helices by the TMHMM server [74]. Western analysis 
(Fig. 2.2.D) of a V5-epitope tagged version of Gpc1p under the control of the GAL1 promoter 
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(GAL1-GPC1-V5) reveals a protein of the expected molecular weight in cells grown in the 
presence of galactose. 
 
2.3.2. Evolutionary analysis  
            Database searches revealed a wide distribution of GPCAT homologues in eukaryotes with 
generally singletons or dual paralogs being present in each species analyzed (Fig. 2.3.). No 
significant protein hits were found in prokaryotes, but homologues were found in major eukaryotic 
organism groups like fungi, animals, plants, algae and several protist clades. However, 
homologues were not found in for example alveolates or heterokonts nor in animal subclades like 
chordates and arthropods. In the maximum likelihood tree (Fig. 2.3.), proteins from animals, fungi 
and Streptophyta (plants and Charophyta) grouped separately as supported by significant bootstrap 
values. For other eukaryotes basal resolution was not observed. Chlorophyta (green algae) 
separated into two groups, one of which being associated (bootstrap value of 90%) with Bodo 
saltans (a euglenozoa belonging to Excavata). Significant groups were also observed for some 
Amobozoa proteins.  
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GPCAT was found present in all analyzed major groups of plants. However, the plant clade 
was characterized by displaying a very small sequence divergence as compared to other organisms 
groups. The plant group revealed a significant group containing seed plants, separate from the 
moss Physcomitrella patens and the lycopod Selaginella moellendorffii. The monocot proteins 
were weakly associated (bootstrap value of 64%), but the major groups of other plants were not  
resolved.  
GPCAT homologues from selected species across the eukaryotic clade were aligned and a radial 
unrooted tree built by maximum likelihood analysis using an LG+G model. The tree is drawn to 
scale and branch lengths measured in substitutions per site. Bootstrap values above 60 are shown 
(in %). Values of at least 95 are bolded. Inset, an expanded subtree for the land plant clade is 
Figure 2. 3. Evolution of the GPCAT family in eukaryotes. 
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shown. Abbreviations: Aca, Acanthamoeba castellanii str. Neff; Acl, Aspergillus clavatus NRRL 
1; Afi, Aristolochia fimbriata; Asu, Acytostelium subglobosum LB1; Ath, Arabidopsis thaliana; 
Atr, Amborella trichopoda; Bba, Beauveria bassiana D1-5; Bsa, Bodo saltans; Bvu, Beta vulgaris 
subsp. Vulgaris; Cba, Cladophialophora bantiana CBS 173.52; Cgi, Crassostrea gigas; Cgl, 
Chaetomium globosum CBS 148.51; Cme, Cyanidioschyzon merolae strain 10D; Cow, 
Capsaspora owczarzaki ATCC 30864; Cre, Chlamydomonas reinhardtii; Ddi, Dictyostelium 
discoideum AX4; Edi, Entamoeba dispar SAW760; Egu, Elaeis guineensis; Emu, Echinococcus 
multilocularis; Kfl, Klebsormidium flaccidum; Lbi, Laccaria bicolor S238N-H82; Lco, 
Lichtheimia corymbifera JMRC:FSU:9682; Lgi, Lottia gigantea; Lth, Lachancea thermotolerans 
CBS 6340; Ltu, Liriodendron tulipifera; Mac, Musa acuminata subsp. Malaccensis; Mbr, 
Monosiga brevicollis MX1; Mci, Mucorcircinelloides f. circinelloides 1006PhL; Mpu, 
Micromonas pusilla CCMP1545; Msp, Micromonas sp. RCC299; Mve, Mortierella verticillata 
NRRL 6337; Nad, Nuphar advena; Ncr, Neurospora crassa OR74A; Ngr, Naegleria gruberi strain 
NEG-M; Nnu, Nelumbo nucifera; Osa, Oryza sativa Indica Group; Ota, Ostreococcus tauri; Ovi, 
Opisthorchis viverrini; Pbr, Plasmodiophora brassicae; Pku, Pichia kudriavzevii; Ppa, 
Physcomitrella patens; Rco, Ricinus communis; Sce, Saccharomyces cerevisiae S288c; Smo, 
Selaginella moellendorffii; Spo, Schizosaccharomyces pombe 972h; Spu, Strongylocentrotus 
purpuratus; Stu, Solanum tuberosum; Uma, Ustilago maydis 521; Zma, Zea mays. See 
supplemental Figure S1 for protein alignment and sequence IDs. 
 
2.3.3 ScGPCAT (Gpc1p) catalyzes the acyl-CoA-dependent acylation of GPC  
Microsomes were prepared from the indicated yeast strains bearing empty vector (EV) or 
expressing GPC1 under the GAL1 promoter (GPC1). The WT yeast was grown in YPD, yeast 
strains carrying a plasmid were grown in YNB medium containing galactose. Microsomes (2 µg 
of protein) were incubated with [14C]choline labelled GPC (0.24 mM) and 18:1-CoA (0.2 mM) for 
30 min at 30oC. The results shown are from triplicate assays ± SD. LPC, lysophosphatidylcholine; 
PC, phosphatidylcholine.  
             
Figure 2. 4. Radioactive lipids formed by microsomes from the indicated strains. 
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 The ScGPCAT activities were assayed with [14C]GPC and non-radioactive 18:1-CoA in 
microsomal preparations from wild type (WT;BY4741), gpc1Δ, ale1Δ and ale1Δ gpc1Δ yeast 
strains expressing either GPC1 under the control of the GAL1 promoter or transformed with empty 
vector (Fig. 2.4.). In WT, the main radioactivity in lipids was found in PC (85%) and the remaining 
radioactivity in LPC. Membranes from ale1Δ transformed with empty vector incorporated about 
the same amount of total radioactivity into lipid as WT but only 21% of the radioactivity was found 
in PC with the remaining activity in LPC, indicating that Ale1p is primarily responsible for LPC 
acylation.  
 
A. The dependence of Gpc1p activity on GPC concentration in the presence of 18:1-CoA. B. The 
acyl-specificity of Gpc1p at optimal GPC concentration (4 mM). The activity was measured as 
incorporation of 14C-activity from [14C]choline labelled GPC into chloroform soluble lipids in the 
presence of acyl-CoA (0.2 mM). Microsomal preparations (2 µg protein) prepared from ale1Δ 
gpc1Δ expressing GAL1-GPC1 were incubated for 4 min at 30°C. ric, ricinoleoyl-CoA. Data is 
given for triplicate assays ± SD.  
Figure 2. 5. Biochemical characterization of Gpc1p 
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Membranes from gpc1Δ bearing empty vector did not incorporate radioactivity into lipids, whereas 
membranes from gpc1Δ cells expressing GPC1 incorporated about 30 times more radioactivity 
into lipids than WT. When GPCAT activity was measured in membranes from ale1Δ gpc1Δ 
harboring GPC1, the total radioactivity incorporated into lipid was reduced approximately 25% as 
compared to the gpc1Δ background and the activity now accumulated primarily in LPC (93%), 
demonstrating again that Ale1p is the main enzyme responsible for the formation of radioactive 
PC from LPC in these assays. The dependence of GPCAT activity on GPC concentration was 
determined in microsomal membranes prepared from ale1Δ gpc1Δ transformed with GAL1-GPC1 
using 18:1-CoA as the acyl donor (Fig. 2.5A). The Km for GPC was found to be 0.45 mM with a 
Vmax of 87 nmol/min. The linearity of the reaction was tested with 18:1-CoA at optimal GPC 
concentration and was found to be essentially linear during 16 min of incubation under the 
incubation condition used (data not shown). The ScGPCAT accepted all the acyl-CoA species 
tested with a preference for 16:0-CoA, polyunsaturated acyl-CoA and the hydroxylated 
ricinoleoyl-CoA (Fig. 2.5B).  
 
Figure 2. 6. Partial alignment of ScGPCAT 
(Saccharomyces cerevisiae; NP_011665.1), RcGPCAT (Ricinus communis; XP_002514086.1), 
AtGPCAT (Arabidopsis thaliana; NP_198396.1) and BnGPCAT (Brassica napus; 
XP_013682687.1). Sequence numbering is according to the full-length protein sequences. The 
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conserved DUF2838 domain is marked above the sequence (V68 to I174 in the A. thaliana sequence). 
Proteins were aligned using Clustal Omega (http://www.ebi.ac.uk) and Geneious 
(http://www.geneious.com) was used for shading background according to conservation. 
 
 
 
A. Specific activity of Arabidopsis thaliana GPCAT (AtGPCAT), S. cerevisiae GPCAT 
(ScGPCAT), Brassica napus GPCAT (BnGPCAT) and Ricinus communis GPCAT (RcGPCAT). 
B. Acyl-CoA specificity of the RcGPCAT. The activity was measured as incorporation of 14C-
activity from [14C]choline labelled glycerophosphocholine (GPC, 4 mM) into chloroform soluble 
lipids in presence of 18:1-CoA (0.2 mM) by microsomal preparations (in A, 2 µg protein; in B. 4 
µg) prepared from ale1∆ gpc1∆ yeast cells expressing the different GPCATs.  Incubations with 
microsomes prepared from gpc1∆ transformed with empty vector gave no incorporation of 
radioactivity into the chloroform phase. Incubation time was in A, 8 min, in B, 4 min. Data is given 
for triplicate assays ± SD. Of the 14C-activity incorporated in lipids, 98-99% was recovered as 
lysophosphatidylcholine and 1-2% as phosphatidylcholine. 
 
2.3.4 Plant homologues of GPC1 catalyze acyl-CoA dependent acylation of GPC when 
expressed in yeast  
                   Sequence similarity was used to identify homologues in Arabidopsis, castor bean 
(Ricinus communis) and oilseed rape (Brassica napus). The Arabidopsis GPCAT shows 25% 
Figure 2. 7. Enzyme activities of plant GPCATs. 
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protein sequence identity to the yeast GPCAT in a 340 residues conserved part from D24 to I362 
in the A. thaliana sequence (Fig. 2.6.). The three different plant GPCATs were expressed in the 
yeast gpc1Δale1Δ strain under the GAL1-promoter and the results compared to those obtained for 
ScGPCAT. The specific activity was highest with ScGPCAT (86 nmol/min/mg protein) whereas 
the plant GPCAT activities ranged from 32 to 52 nmol/min/mg protein (Fig. 2.7.A). Microsomal 
preparations from castor bean seeds have high GPCAT activity [50] and the plant accumulates 
seed triacylglycerols with about 90% of the fatty acid being the hydroxy acid, ricinoleic acid. This 
fatty acid is synthesized by hydroxylation of oleoyl groups esterified to the sn-2 position of PC 
[75]. It was therefore of interest to investigate the acyl-CoA specificity of the castor GPCAT. Like 
yeast GPCAT, the castor GPCAT accepted all the acyl-CoAs tested, including ricinoleoyl-CoA 
(Fig. 2.7.B), although with somewhat different acyl specificities as compared to the yeast enzyme.  
 
 
Incorporation of 14C-activity from [14C]choline labelled glycerophosphocholine (GPC, 0.5 mM)) 
or [14C]ethanolamine labelled glycerophosphoethanolamine (GPE, 0.5mM ) into chloroform 
soluble lipids in the presence of 18:1-CoA (0.4mM). Microsomal preparations (40 µg of protein) 
of ale1∆ gpc1∆ yeast cells with overexpressed GPC1 or empty vector (EV). The radioactivity 
resided in LPC in assays with added [14C]GPC and in lysophosphatidylethanolamine in case of 
Figure 2. 8. Acylation of glycerophosphoethanolamine 
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added [14C]GPE. Incubation time was 20 min and the temperature was 30°C. Data is given for 
triplicate assays ± SD. 
 
2.3.5. Gpc1p catalyzes acylation of glycerophosphoethanolamine (GPE) with acyl-CoA           
Stålberg et al. [49] reported that yeast also possessed acyl-CoA:GPE acyltransferase activity. In 
order to test if this activity was catalyzed by ScGPCAT, we performed assays with [14C]GPE and 
18:1 acyl-CoA in microsomal preparations of ale1∆ gpc1∆ strain transformed with GPC1 or empty 
vector (Fig. 2.8.). No incorporation of radioactivity into lipids was seen with empty vector, but 
upon expression of GPC1 radioactive lysophosphatidylethanolamine (LPE) accumulated, albeit at 
about 25% of the amount of LPC formed when [14C]GPC was provided. Thus, Gpc1p also 
catalyzes the acylation of GPE with acyl-CoA. 
 
2.3.6. GPCATs from yeast and plants catalyze transacylation reactions  
 
Radioactive lipids formed in incubations of microsomes (40 µg of protein) prepared from yeast 
lacking or expressing the indicated genes. Incubations contained [14C]glycerophosphocholine 
(0.24 mM) in the absence of added acyl-CoA and were performed for 90 min at 30°C. The results 
shown are from triplicate assays ± SD. LPC, lysophosphatidylcholine; PC, phosphatidylcholine. 
Strains contained empty vector (EV) or expressed GPC1 from GAL1 promoter (GPC1).Yeast of 
Figure 2. 9. Transacylation activity of GPCAT. 
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WT that was used for microsomal preparation was grown in YPD, yeast strains containing 
plasmids were grown in YNB medium containing galactose. 
 
The incorporation of [14C]choline labelled GPC into lipid in the absence of exogenous acyl-
CoA was assayed in yeast membranes (Fig. 2.9.). Membranes from gpc1Δ did not incorporate any 
radioactivity into lipids whereas the WT and the gpc1Δ transformed with pGAL-GPC1 
incorporated similar amount of radioactivity into both LPC and PC. The lack of Ale1p had little 
or no effect on the incorporation of radioactivity into LPC or PC (Fig. 2.9.).  
 
These experiments indicate that GPCAT is responsible for the production of radioactive LPC from 
[14C]GPC in the absence of exogenous acyl-CoA and that the second acylation step, the acylation 
of LPC to PC, is independent of Ale1p activity in the absence of exogenous acyl-CoA. Although 
GPCAT activity was essential for incorporation of radioactivity from [14C]GPC into lipids in 
absence of acyl-CoA, its activity did not appear to be a rate limiting factor in WT since the WT 
and GPC1 overexpressing strain incorporated similar amount of radioactivity into lipids. A time-
course of incorporation of [14C]GPC into lipids in the absence of added acyl-CoA was performed 
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with membranes from ale1∆ gpc1∆ cells transformed with ScGPCAT or RcGPCAT. The two 
enzymes gave similar incorporation patterns (Fig. 2.10).  
Time-course incorporation of 14C-activity from [14C]choline labelled glycero-3-phosphocholine 
(GPC, 4 mM)) into LPC in incubations in the absence of added acyl-CoA by microsomal 
preparations (40 µg of protein) prepared from yeast ale1∆ gpc1∆  cells overexpressing ScGPCAT 
(GPC1) (A) or castor bean GPCAT (RcGPCAT) (B). The enzyme rates for ScGPCAT and 
RcGPCAT in the absence of acyl-CoA was 0.45 and 0.23 nmol/min/mg, respectively, during the 
first 15 min. Corresponding incubations with microsomes prepared from the gpc1∆ale1∆ strain 
transformed with empty vector gave no incorporation of radioactivity into the chloroform phase, 
indicated with a star at 90 min incubation in the graph (A). Data is given for triplicate assays ± SD.  
Alternative mechanisms could explain the observed incorporation of radioactivity from 
[14C]choline- GPC into LPC and PC. The simplest explanation is transfer of an acyl groups from 
membrane lipids to the added GPC. Among possible acyl donors for such acylation, we tested non-
radioactive LPC in combination with [14C]choline-labelled GPC and found that membranes 
derived from ale1∆gpc1∆ bearing GAL1-GPC1 rapidly formed radioactive LPC, whereas 
membranes from cells transformed with empty vector totally lacked this capacity (Fig.2.11). When 
Figure 2. 10. Transacylation activity of GPCAT over time. 
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corresponding incubations were performed with membranes prepared from ale1∆ cells (containing 
an endogenous GPC1 gene), radioactive LPC accumulated at about 10% of the rate which occurs 
when GPC1 is overexpressed with the GAL1-GPC1 plasmid (Fig. 2.11).  
 
Incorporation of 14C-activity from [14C]choline labelled GPC (1 mM) into lipids in the presence 
of non-radioactive 18:1-LPC (0.5 mM) and microsomal fractions (40 µg of protein). Microsomal 
fractions were from an ale1∆ gpc1∆ strain overexpressing GPC1(scGPCAT) or from an ale1∆ 
strain expressing empty vector (EV). LPC constituted 98-99% and PC 1-2% of the radioactive 
chloroform soluble lipids after 40 min. The activity of ScGPCAT during the first 10 min, 
calculated on the formed radiolabelled LPC,  was  9.5nmol/min/mg protein. Corresponding 
incubations with microsomes prepared from ale1∆ gpc1∆ transformed with empty vector gave no 
incorporation of radioactivity into the chloroform phase, indicated with a star at 40 min incubation 
in the graph. Data is given for triplicate assays ± SD.  
 
Figure 2. 11. Time course for transacylation activity of ScGPCAT in the presence of 
added LPC. 
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Radioactive lipids formed in incubations of microsomes (40 µg of protein) prepared from ale1∆ 
gpc1∆ expressing ScGPCAT. [14C]Glycerol labeled GPC (0.2 mM) and non-radioactive 18:1-LPC 
or ricinoleoyl-LPC (ric-LPC) (0.1 mM) or an equimolar mixture of both (0.05+0.05 mM) for 30 
min. Incubations with microsomes prepared from ale1∆ gpc1∆ strain transformed with empty 
vector gave no incorporation of radioactivity into the chloroform phase. Panel A. The results 
shown are from triplicate assays (± SD). Panel B. Relative distribution of molecular species of PC 
formed. PC from triplicate assays (Panel A) were pooled before phospholipase C treatment to 
obtained DAG for separation of molecular species (see Materials and Method section). 0-OH-X, 
1-OH-X and designates lipids with no and one ricinoleoyl groups, respectively. 
 
This demonstrates that the transacylation rate is a function of the level of GPCAT activity 
when the LPC concentration is not rate limiting, as it was in experiment presented in Fig. 2.9. and 
2.10. The rate of radioactivity appearing in LPC during the first 10 min with GAL1-GPC1 was as 
high as 9.5 nmol/min/mg protein, which is 11% of the acylation rate with 18:1-CoA at optimal 
GPC concentration with the same membranes. Apart from direct acyl transfer from added LPC, 
there could be other explanations for the formation of radioactive LPC in assays in which 
unlabelled LPC but no acyl-CoA had been provided. By adding non-radioactive ricinoleoyl-LPC, 
Figure 2. 12. LPC as donor in transacylation activity. 
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which could be separated from LPC with non-hydroxylated acyl groups by TLC, we  demonstrated  
that the added [14C]glycerol labelled GPC  received 90% of its acyl groups from the added LPC 
(Fig. 2. 12A). This experiment gave conclusively evidence that GPCAT catalysed the transfer of 
acyl groups from added non-radioactive LPC to [14C]GPC, and thus forming non-radioactive GPC 
and [14C]-labelled LPC molecules. 
Some radioactive PC was also formed in these assays (Fig. 2. 12). When the radioactivity 
in the different PC molecular species was analyzed in incubations with added ricinoleoyl-LPC , 
species with one ricinoleoyl group had 96 % of the activity with the remainder being [14C]PC with 
no ricinoleoyl groups (Fig. 2. 12B). These results show that the second acylation step is not using 
added ricinoleoyl-LPC in a LPC:LPC transacylase reaction but receive acyl groups from some 
other lipid(s). 
 
 
 
Incorporation of 14C-activity from [14C]choline labelled GPC (1 mM)) into chloroform soluble 
lipids in presence or absence of added (0.4 mM) 18:1-lysophsophatidic acid (LPA), 18:1-
Figure 2. 13. Lysolipids as acyl donors for ScGPCAT (Gpc1p) activity. 
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lysophosphatidylcholine (LPC), 18:1-lysophosphatidylethanolamine (LPE) and 18:1-
lysophosphatidylserine (LPS) by microsomal preparations (60 µg of protein) prepared from yeast 
ale1∆ gpc1∆ cells with overexpressed GPC1. Corresponding incubations with empty vector gave 
no incorporation of radioactivity into the chloroform phase (data not shown). Incubation time was 
60 min and temperature was 30°C. Data is given for triplicate assays ± SD. PC, 
phosphatidylcholine. 
 
2.3.7. Gpc1 catalyzes the transacylation of acylgroups from lysophospholipids other than 
LPC  
                We investigated if lysophospholipids other than LPC could serve as acyl donors for the 
acylation of GPC by Gpc1p (Fig. 2. 13). LPE could donate acyl groups at about 25% of the 
efficiency with LPC. Incorporation of radioactivity into LPC from added lysophosphatidylserine 
was low, but significantly higher than in absence of added lysolipids, whereas no increase was 
seen with added lysophosphatidic acid (Fig. 2. 13).  
 
The indicated strains were grown to logarithmic phase in galactose medium and the distribution of 
the radioactivity between the TCA and membrane extracts was determined. Strains contained 
either empty vector (EV) or GPC1 under the control of the GAL1 promoter (GAL1-GPC1). Data 
represent average of 3 independent cultures ±SD. A t-test was performed to determine significance 
as indicated by brackets (*P≤ 0.05; **P ≤ 0.0008). 
 
Figure 2. 14. In vivo incorporation of [3H]GPC. 
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2.3.8. In vivo labeling indicates a physiological role for Gpc1p in PC biosynthesis  
                In vivo radiolabeling experiments were performed to examine the role of Gpc1p-
mediated GPC acylation in cellular PC biosynthesis. For these studies, the medium contained 
[3H]GPC and a low concentration of phosphate in order to induce transcription of the GIT1 
encoded permease [76] responsible for the uptake of GPC into the cell [31]. Following growth to 
logarithmic phase, cells were separated into membrane and TCA-extractable fractions and the 
percentage of radioactivity in each fraction determined. As shown in figure 2.14, loss of GPC1 
(compare WT +EV to gpc1Δ + EV) resulted in less incorporation of [3H]GPC radioactivity into 
the membrane fraction and a concomitant increase in the intracellular fraction. Importantly, the 
gpc1Δ strain containing the GAL1-GPC1 plasmid  
 
TABLE 2. 1. 
Values for intracellular percentages are derived from Fig 2. 13 
 
displayed a distribution of radioactivity similar to WT. When GPC1 was overexpressed in the WT 
strain, there was no change in the distribution of counts as compared to WT containing empty 
vector. This suggests that expression of GPC1 from its single genomic copy, as occurs in the WT 
strain, is not rate-limiting for radioactive flux into the membrane fraction under these conditions. 
As expected, a gde1Δ mutant lacking the glycerophosphodiesterase responsible for GPC 
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hydrolysis (see Fig. 1) [31] exhibited a greater proportion of counts in the internal fraction as 
labelled GPC (Table 1) as compared to WT (compare WT + EV to gde1Δ + EV). In contrast to the 
WT strain, overexpression of GPC1 in gde1Δ did result in an increase in membrane counts and a 
decrease in intracellular counts as compared to the empty vector control. This suggests that in the 
presence of high intracellular levels of substrate (as engendered by loss of Gde1p), GPC1 
expression from the single genomic copy is rate-limiting for incorporation of [14]GPC into 
membrane. In all cases, the radioactivity in the membrane fraction was found only in PC, 
suggesting that the LPC produced under these conditions is either rapidly converted to PC or 
deacylated back to GPC. The TCA-extractable fractions consisted of GPC and free choline (Table 
1). These results confirm a cellular role for Gpc1p in the synthesis of PC via acylation of GPC. 
Stålberg et al. [49] demonstrated that the generally accepted assumption that GPC cannot 
be acylated and thus could not be a substrate for the synthesis of PC was incorrect. These authors 
[49] demonstrated acyl-CoA-dependent GPC acylation (GPCAT reaction) in microsomal fractions 
from yeast and later Lager et al. [50] showed the same enzyme reaction in microsomal fraction 
from plants. Here we report on the cloning and characterization of the GPCAT-encoding genes 
from yeast and plants. The GPCAT genes have not been annotated for any function in yeast or 
plant databases and do not fall into MBOAT or acyl-CoA:glycerol-3-phosphate acyl transferase 
GPAT (PhospholipidsB type) families of acyltransferases. GPCAT is also unique in that it has, in 
addition to acyl-CoA acyltransferase activity, LPC:GPC transacylase activity. Our labeling studies 
employing intact yeast cells demonstrate the in vivo relevance of these enzymatic activities. It is 
remarkable that despite having acyl-CoA acyltransfer and transacylation activity, the GPCAT 
enzymes lack any recognizable domain present in other such enzymes where the catalytic activity 
has been established.  
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As is the case with any enzyme, the gene/enzyme relationship cannot be unequivocally 
established until the enzyme is purified to homogeneity. None-the-less, the preponderance of 
evidence indicates that Gpc1p harbors catalytic activity and is not a regulatory protein or a non-
catalytic subunit of a larger complex. First of all, plant GPCAT proteins are functional in yeast, 
despite having only 25% amino acid identity (see Fig. 2. 6) with Gpc1p. Secondly, when GPC1 is 
overexpressed, the transacylation and acylation activities are ten to forty times higher as compared 
to the wild type condition. These findings argue against a regulatory function or being a subunit 
of an enzyme for the gene product. 
 Homologues of GPCAT are widely distributed among eukaryotic organisms but no 
homologues were found in prokaryote clade. Interestingly, the plant clade showed a very low 
sequence divergence as compared to other eukaryotic groups. A common reason for low sequence 
divergence is a low substitution rate being a consequence of protein-protein interactions [77]. 
Therefore, we investigated the Membrane-based Interactome Network Database (M.I.N.D.) which 
contains high-confidence data of protein-protein interaction for Arabidopsis membrane proteins, 
based on the split-ubiquitin system in yeast [78].  Four proteins, out of 151 hits, were related to 
acyl lipid metabolism and found to interact with AtGPCAT, when excluding interactions tested 
positive in only one out of two assays in the primary screen. Three of these hits are associated with 
sphingolipids (At2g31360; At3g06470; At1g69640), whereas the fourth hit belongs to the family 
of oleosin proteins (At2g25890). Further studies are needed to resolve if plant-specific protein-
protein interactions are a reason for the low sequence divergence in plants.  
The physiological function of GPCAT in yeast and plants remains to be explored. At face 
value, GPCAT activity may be part of a recycling pathway to restore PC levels following PC 
turnover via deacylating phospholipases. On a more complex level GPCAT has been suggested to 
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be involved in various aspects of acyl editing and phospholipid remodeling in yeast and plants [60, 
79, 80]. Overall, it can be assumed that PC homeostasis is maintained by the concerted action of 
GPCAT, lyso-phospholipid lipases and lysophosphatidylcholine acyltransferases (LPCATs), in 
addition to the major pathways of PC biosynthesis (the CDP-choline and methylation pathways). 
It should be noted that GPC is believed to only be formed via deacylation of PC and if so, GPCAT 
cannot contribute to any net synthesis of PC if it is not provided to the cell from outside. Since 
plasma membrane GPC transporters are found in yeast [30, 31] and fungi [81] exogenous GPC 
could however under certain environmental conditions contribute to net synthesis of PC via 
GPCAT in these cells. In all cells, GPCATs would contribute to an acyl editing whereby acyl 
groups from the acyl-CoA pool can be inserted into the sn-1 position of PC via LPC formation 
from GPC. Since we show that GPCAT also can acylate GPE with acyl-CoA at about the 25% of 
the rate of GPC, it could also be involved in acyl editing of PE, similar to what we proposed for 
PC editing.  
Thus, GPCAT catalyzed acylation of GPC by acyl-CoA can be predicted to have a role in 
maintaining PC homoeostasis and in acyl editing of this phospholipid. We have now shown that 
the incorporation of [14C]GPC into lipids observed in plant microsomal membranes in absence of 
acyl-CoA [50] is due to GPCAT-catalyzed transacylation of acyl groups from LPC to GPC. Since 
this reaction does not form any new lipid molecular species it might function as a GPC transporter 
across intracellular membrane and compartments and/or catalyzing the movement of LPC from 
one leaflet of the membrane to the other. GPCAT can also transfer acyl groups from LPE to GPC 
in forming GPE and LPC, albeit at a lower rate than if LPC and GPC were substrates. Thus, 
GPCAT could also be involved in exchanging acyl groups between PC and PE.      
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 We show here that the [14C]LPC formed from [14C]GPC by transacylation from added 
LPC was to some extent further converted to [14C]PC and that this transfer did not involve 
LPC:LPC transacylation (LPCT), at least not with LPC containing ricinoleoyl moiety. LPCT 
reactions were demonstrated in microsomal preparations from developing safflower seeds [50]. 
The enzyme(s) responsible for the formation of PC from LPC in the yeast microsomes remains to 
be established. 
The strategy we used for identifying the GPCAT gene is an example of how the function 
of a non-annotated gene can be established. Our approach differs from most current methods for 
identifying the function of genes, which primarily rely on forward and reverse genetics and require 
an observable phenotype or extrapolation by homology to genes with a priori known function. 
More than 20% of all genes encoding putative proteins in any eukaryote are still not reliably 
annotated with experimentally defined functions and their functions are not accessible via forward 
or reverse genetics because silencing or overexpression do not yield obvious phenotypes. We 
predict that discovery of many new functions and novel enzyme reactions will require renewed 
emphasis on classical biochemical methods coupled with the increasingly powerful molecular 
biology and high through-put technologies.  
The identification of the GPCAT genes now allows for determining their physiological 
functions by forward and reverse genetics in the plethora of eukaryotic clades where homologues 
are present and such work is now in progress in our laboratories. 
 
2.4. EXPERIMENTAL PROCEDURES 
2.4.1. Chemicals - [1-14C]Radioactive fatty acids, [14C]choline, [14C]glycerol-3-phosphate were 
purchased from Perkin-Elmer and [14C]ethanolamine from American Radiochemicals. Non-
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radioactive fatty acids and CoA were obtained from Larodan (Malmö, Sweden). Di-ricinoleoyl-
PC was kindly provided by ENI/Metapontum Agrobios, Metaponto, Italy. Ricinoleoyl-LPC was 
produced by phospholipase A2 (from Naja naja, Sigma) treatment of di-ricinoleoyl-PC. All other 
non-radioactive fine chemicals were obtained from Sigma Chemical Company.  Acyl-CoAs were 
prepared according to the method described by Sanchez et al. [82]. [14C]Choline-labelled GPC and 
[14C]ethanolamine labelled GPE were obtained by growing WT yeast cells (SCY62) with 
[14C]choline or [14C]ethanolamine and purifying the labelled PC or PE and deacylating it according 
to [50]. The specific activity of the [14C]GPC and varied between 40 000 dpm/nmol to 86 000 
dpm/ nmol whereas [14C]GPE only had about 200 dpm/nmol. [14C]Glycerol labelled GPC was 
prepared by incubating microsomal preparations from developing safflower seeds with 18:1-CoA 
and [14C]G3P according to Guan et al. [83]. After extracting the lipids from the assay into 
chloroform [84] the formed [14C]glycerol labelled PC was separated by TLC and de-acylated as 
above. The specific activity of the [14C]glycerol labelled GPC varied between 26 000 dpm/nmol 
and 53 000 dpm/nmol.  
 
2.4.2.Yeast Strains, Plasmids and Microsomal Preparations - The yeast strains used are from the 
yeast knock out Mat a collection (Thermo Scientific) in the background BY4741 (see Table 2). 
The double yeast mutant (ale1∆ gpc1∆) was obtained by one-step PCR-mediated gene disruption 
using the gpc1∆ strain as background. The ALE1 gene was replaced by the LEU marker (primers 
used: 
5'ATGTACAATCCTGTGGACGCTGTTTTAACAAAGATAATTACTGTGCGGTATTTCACAC
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CG3', 
5'CTACTCTTCCTTTTTTGAAATAGGCTTTGGTGAGTAACCAGATTGTACTGAGAGTGC
AC3'). 
BY4741 was used as WT in GPCAT assays. The genes encoding GPCAT from yeast 
(YGR149W) and Arabidopsis (At5g35460) were amplified by PCR, whereas the genes from castor 
bean (XM_002514040 ) and oilseed rape (BnaA04g07370D) were ordered synthetically 
(GenScript) by using known sequence information. The Gateway® system was used to clone into 
the yeast expression vector pYes-DEST52, which places genes under control of the GAL1 
promoter (referred to as GAL1-GPC1 in text and figures). For Western analysis, GPC1 was cloned 
into pYES2.1 which contains a C-terminal V5-6xHIS epitope tag (referred to as GAL1-GPC1-V5 
in text and figures).  The vector pYES2 was used as the empty vector control (EV in figures). 
Microsomal membranes were prepared according to the method described in [50].  
 
2.4.3. Yeast-based screen for identifying GPCAT-encoding gene - The yeast knock-out Mat a 
collection from Thermo Scientific was used for the screen. The deletion strains were transferred 
from the glycerol stock to a microplate containing solid YPD and grown for 2-3 days at 30°C then 
plated on YPD plates and grown for additional 2-3 days. Individual yeast strains were transferred 
to 2 ml tubes together with with 0.5 mm zirconia/silica beads and 0.1M phosphate buffer, pH 7.2 
and disrupted (8x30s) using a Mini Beadbeater-8 (Biospec Products). After centrifugation 20µl of 
the yeast extract was incubated with 100nmol [14C]GPC, 100nmol [14C]G3P, 1mg BSA, 20mM 
EDTA and 20nmol 18:1-CoA for 20 min at 30°C. The reactions were terminated by 110µl 
MeOH:CHCl3: HAc (50:50:1v/v/v), vortexed and centrifuged. The chloroform phase was applied 
to a TLC plate (Silica 60, Merck) and the lipids were separated in CHCl3: MeOH:HAc:H2O 
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(90:20:20:3v/v/v/v). The radiolabeled lipids were visualized with Instant Imager (Packard 
Instrument Co.) electronic autoradiograph. 
 
2.4.4. Sequence alignment and phylogenetic tree - Database searches were carried out with the 
Arabidopsis and yeast GPCAT protein as queries using BLASTp and tBLASTn against the 
Genbank database at the National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov). Proteins were selected for inclusion based on phylogenetic 
distribution of the species. Complementary searches were carried out in genome databases for 
Klebsormidium flaccidum 
(http://www.plantmorphogenesis.bio.titech.ac.jp/~algae_genome_project/klebsormidium/) and 
Liriodendron tulipifera, Aristolochia fimbriata and Nuphar advena (http://ancangio.uga.edu/). All 
hits used had e-values <10-11. Back-searches by BLASTp against A. thaliana and yeast GPCAT 
were carried out to verify homology. The selected sequences were also analysed by BLink (NCBI) 
to exclude contaminants. Alignments were made using the T-Coffee PSI/TM-Coffee [85] web-
service (http://tcoffee.crg.cat/apps/tcoffee/do:tmcoffee), unless otherwise indicated in the figure 
legend. Alignments were subjected to maximum likelihood analysis in MEGA 6.0.6 [86], using an 
85% limit for partial gaps. Bootstrap testing was conducted with 1000 replicates. 
 
2.5.5. Microsomal enzyme assay - The enzyme assays were performed with microsomal 
membranes prepared from recombinant yeast cells and yeast transformed with empty vector as 
indicated in the figure legends. Microsomal membranes, radioactive and non-radioactive 
substrates were incubated in mixtures at concentration and times stated in the figure legends in 
0.1M phosphate buffer, pH 7.2 with 1% of BSA (essentially fatty acid free) in a final volume of 
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50 µl at 30°C with shaking (250 rpm). LPC were added to the assay mixture dissolved in phosphate 
buffer, pH 7.2. 
 
2.5. 6. Lipid Extraction, Separation, and Analysis - The microsomal assays were terminated by 
addition of 170 μl of 0.15M acetic acid and 500 μl of CHCl3:MeOH (1:1, v/v) and vortexed. After 
centrifugation, the chloroform phase was removed, and an aliquot was taken to liquid scintillation 
counting of the radioactivity. The remaining chloroform phase from the extraction of the assays, 
after removal of an aliquot to liquid scintillation, was applied on TLC plate (Silica 60, Merck), and 
the plate was developed in CHCl3:MeOH:HAc:H2O (85:15:10:3.5 v/v/v/v.). Radioactive spots 
were visualized and identified by Rf values of authentic standards, and the relative amount of 
radioactivity in each spot was determined by Instant Imager (Canberra Packard Instrument Co.) 
electronic autoradiograph. Absolute amounts of radioactivity in each spot were calculated from 
the total amount of radioactivity in the chloroform phase as determined by liquid scintillation. In 
the experiments where the molecular species of radioactive LPC and PC were determined, the lipid 
extract from the assays were separated on TLC twice with CHCl3:MeOH:HAc:H2O (85:15:10:3.5 
v/v/v/v). This separated ricinoleoyl-LPC from LPC with non-hydroxylated acyl groups and the 
relative proportions of radioactivity between these LPC species were determined by 
autoradiography. The PC species with hydroxylated acyl groups and no hydroxylated acyl groups 
were not clearly separated and these PC species were eluted together from the gel and treated with 
PLC (from Clostridium perfringens, Sigma). The resulting diacylglyerols species were then 
separated on TLC developed with hexane/diethyl ether/acetic acid (70:140:3 v/v/v). The relative 
radioactivity between diacylglycerols with no, one and two ricinoleoyl groups were then 
determined by autoradiography. 
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2.5.7. In vivo labeling and fraction isolation - WT (BY4741), gpc1Δ and gde1Δ strains contained 
either empty vector (pYES 2.1) or GAL1-GPC1 (pYES 2.1-YGR149w). Cultures were maintained 
aerobically at 30°C in yeast nitrogen base (YNB) medium containing 2% galactose and altered to 
lack inositol and contain a low level of KH2PO4 (200 μM) to induce expression of the Git1 
transporter for GPC uptake. Amino acid concentrations were as described [87],  but uracil was 
removed to maintain the plasmids. For labeling experiments, the medium was supplemented with 
5 μM of 3H-choline-GPC and grown to log phase before harvesting. A membrane fraction and 
TCA-extractable intracellular fraction were isolated as described previously [88]. The percentages 
of radioactive counts in each fraction were determined using a liquid scintillation counter.  
 
2.5.8. Analysis of choline-containing metabolites and lipids following in vivo labeling - The water-
soluble choline-containing metabolites were separated using anion exchange chromatography as 
described in [88]. Standards were used to verify the separation procedure and label incorporated 
into each metabolite was quantified using liquid scintillation counting. Lipids were extracted from 
the membrane fraction as described previously [88] and separated by TLC as described for the in 
vitro assays.  
 
2.5.9. Western blotting- Protein extraction and quantification were performed as described in [76].  
Protein (75 g) was loaded into each lane of a Mini-PROTEIN 4-15% gel (BIO-RAD). The semi-
dry transfer was performed onto a PVDF membrane using TRANS-BLOT SD (BIO-RAD). 
Membrane was blocked in blocking buffer (5% milk in tris buffer saline- 0.1% Tween 20 solution 
(TBST) for 60 min at room temperature. Primary antibody was used against V5 epitope 
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(Monoclonal V5 Epitope Tag Antibody (Invitrogen, catalog no. R960-25) at a dilution of 1:1000 
in TBST containing 5% BSA and incubated at 4°C for overnight. The primary antibody was then 
removed and membrane was washed trice with TBST for 10 min each. The goat anti-Mouse 
secondary antibody (Li-Cor Biosciences, catalog no. 926-322-10) was used at a dilution of 
1:10,000 in TBST containing 5% milk. Membranes were incubated in secondary for 60 min at 
room temperature. Secondary was removed, and the membrane was washed trice with TBST for 
10 min each. Finally, membrane was visualized using Odyssey FC imaging system. Glucose-6-
phosphate dehydrogenase (G6PD) was used as the loading control. The same procedure as above 
was employed for G6PD; primary antibody was anti-G6PD (Sigma-Aldrich, catalog no. HPA000-
834) and secondary antibody was goat anti-rabbit (Li-Cor Biosciences, catalog no. 926-68071).  
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3.1. ABSTRACT 
Phospholipase B–mediated hydrolysis of phosphatidylcholine (PC) results in the formation 
of free fatty acids and glycerophosphocholine (GPC) in the yeast Saccharomyces cerevisiae. GPC 
can be reacylated by the glycerophosphocholine acyltransferase Gpc1, which produces 
lysophosphatidylcholine (LPC), and LPC can be converted to PC by the lysophospholipid 
acyltransferase Ale1. Here, we further characterized the regulation and function of this distinct PC 
deacylation/reacylation pathway in yeast. Through in vitro and in vivo experiments, we show that 
Gpc1 and Ale1 are the major cellular GPC and LPC acyltransferases, respectively. Importantly, 
we report that Gpc1 activity affects the PC species profile. Loss of Gpc1 decreased the levels of 
mono-unsaturated PC species and increased those of di-unsaturated PC species, while Gpc1 
overexpression had the opposite effects. Of note, Gpc1 loss did not significantly affect 
phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine profiles. Our results 
indicate that Gpc1 is involved in post-synthetic PC remodeling that produces more saturated PC 
species. qRT-PCR analyses revealed that GPC1 mRNA abundance is regulated coordinately with 
PC biosynthetic pathways. Inositol availability, which regulates several phospholipid biosynthetic 
genes, down-regulated GPC1 expression at the mRNA and protein levels and, as expected, 
decreased levels of monounsaturated PC species. Finally, loss of GPC1 decreased stationary phase 
viability in inositol-free medium. These results indicate that Gpc1 is part of a post-synthetic PC 
deacylation/reacylation remodeling pathway (PC-DRP) that alters the PC species profile, is 
regulated in coordination with other major lipid biosynthetic pathways and affects yeast growth. 
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3.2. Introduction 
Cellular membranes must adjust their lipid composition in response to internal and external 
cues. These adjustments occur through the coordinated control of multiple metabolic activities, 
including biosynthetic enzymes involved in lipid synthesis, phospholipases involved in lipid 
turnover, and acyltransferases involved in lipid remodeling. Because lipid composition affects the 
biophysical properties of the membrane, these alterations are crucial to cellular function [61, 89]. 
Defects in lipid metabolism are associated with multiple disease states and cellular dysfunctions 
[54, 90-94]. 
Phosphatidylcholine (PC) is the major glycerophospholipid in most eukaryotic membranes. 
In Saccharomyces cerevisiae, bulk synthesis of phosphatidylcholine (PC) occurs primarily via the 
PE methylation pathway and the CDP-choline (Kennedy) pathway (Fig. 3.1). In the absence of 
exogenous choline, the CDP-choline pathway does not contribute to net PC synthesis, but is 
important for recycling choline derived from turnover pathways. Characterized turnover pathways 
include the production of phosphatidic acid (PA) and free choline via phospholipase D activity 
(Spo14/Pld1) [5, 95] and the production of free fatty acids and GPC via phospholipases of the B 
type encoded by NTE1 and PLB1 [25, 26, 28]. GPC can subsequently be degraded to free choline 
and glycerol-3-phosphate by the glycerophosphodiesterase, Gde1 [31, 96]. Based on in vitro 
experiments with yeast extracts,  another route for GPC conversion, namely its acylation to LPC, 
was described [49]. Recently, a gene encoding such a GPC acyltransferase activity, GPC1, was 
identified [52]. After LPC formation by Gpc1, the lysophospholipid acyltransferase, Ale1, can act 
to form PC [39]. Overall, the degradation of PC to form GPC, followed by its stepwise reacylation 
to PC, defines a novel PC deacylation/reacylation remodeling pathway (PC-DRP) for PC 
biosynthesis [25, 52, 97]. 
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PC, like other phospholipids, consists of multiple molecular species based on acyl chain 
differences at the sn-1 and sn-2 position of the glycerol backbone. The repertoire of fatty acids in 
yeast is relatively simple as compared to the higher eukaryotes, consisting primarily of C16 and 
C18 fatty acids with either one or no double bond [57]. Thus, the four major PC species observed 
through mass spectrometry have the following acyl chain combinations: 32:1PC (mono-
unsaturated) consists of C16:0 and C16:1, 32:2PC (di-unsaturated) consists of C16:1 and C16:1, 
34:2PC (di-unsaturated) consists of C16:1 and C18:1, 34:1PC (mono-unsaturated) consists of 
either C16:0 and C18:1 (this being the predominant acyl chain combination) or C16:1 and C18:0 
[38, 60, 98]. 
The steady state PC molecular species profile is the result of the molecular specificity of 
the PC biosynthetic routes combined with post synthetic acyl chain exchange [38]. The PE 
methylation pathway produces predominantly di-unsaturated PC species, whereas the CDP-
choline pathway produces a more mixed profile [38, 99]. Furthermore, a number of studies have 
provided evidence for the post-synthetic remodeling of PC species [57, 58]. Indeed, PC remodeling 
was clearly demonstrated by pulse-chase studies using deuterium labeled (methyl-D3)-methionine 
followed by ESI-MS/MS analysis. Those studies revealed a post-synthetic increase in mono-
unsaturated PC species (32:1, 34:1) at an expense of di-unsaturated PC species (32:2, 34:2) [99]. 
Prior to this work, an acyltransferase responsible for remodeling PC to more saturated species in 
S. cerevisiae had not been identified. 
Here we undertook a more thorough examination of PC remodeling via PC-DRP and the 
role of the GPC acyltransferase, Gpc1. Importantly, we report that Gpc1 is a key player in post-
synthetic PC remodeling events that result in more saturated PC species. In addition, we find that 
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Gpc1 is regulated with respect to other aspects of lipid metabolism and that loss of Gpc1 impacts 
stationary phase viability. 
 
3.3. EXPERIMENTAL PROCEDURES  
 
3.3.1. Strains, Plasmid, Media and Growth Conditions 
 The S. cerevisiae strains used in this study are presented in Table 1. Strains were 
maintained aerobically at 30°C with shaking or on a roller drum. Growth was monitored by 
measuring optical densities at 600 nm (A600) using BioMate3 Thermo Spectronic 
spectrophotometer. Media used in this study were yeast peptone dextrose (YPD) or yeast nitrogen 
base (YNB) with 2% glucose and amino acid composition as described in [87]. The YNB medium 
was made according to DIFCO manual, but lacking inositol. For studies requiring inositol, 75 μM 
of inositol was provided. Transformations of autonomously replicating plasmids were performed 
using the lazy bones plasmid transformation protocol as described [100]. For integrating DNA into 
the genome, the high efficiency transformation procedure was used [101]. The empty vector, 
pRS426 and vector overexpressing GIT1 gene, ADH-GIT1 were from [102]. 
 
3.3.2. Construction of Deletion Strains 
 The wild type (BY4742) S. cerevisiae strain was purchased from Open Biosystems 
(Thermo Scientific, Huntsville, AL). The deletion strains used in this study were made using PCR-
based homologous recombination technique as described in [88, 103]. Nutritional markers, LEU2 
and URA3, were amplified from pRS415 and pRS416, respectively, using primers listed in Table 
2.   
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3.3.3. Construction of Chromosomal C-terminal 3xHA Tag for GPC1 
 The 3xHA-URA3 cassette was amplified from plasmid pPMY-3xHA [104] using the 
primer set shown in Table 2. The PCR product was transformed into WT strain, and transformants 
were selected on YNB plates lacking uracil. Control PCR was performed on genomic DNA 
extracted from transformants to verify the integration of the entire cassette into the genome. To 
counter-select against the URA3 gene, the verified colonies were then reselected on a YNB plate 
containing 1mg/ml of 5-fluoroorotic acid (5-FOA). Genomic DNA was extracted from colonies 
that grew on 5-FOA plates and were used as template to check for the insertion of 3xHA at C-
terminal end. Colonies producing the correct amplicon are JPV846 (WT+GPC1-3xHA), used in 
the western blot analyses.   
 
3.3.4. In vivo Labeling and Lipid Isolation 
 For the long-term labelling experiment represented in Fig 2A, strains were grown in YNB 
inositol-free medium containing 5 μM of 14C-GPC (200,000 cpm/ml) (ARC 3880) and a low 
concentration of KH2PO4 (200 μM) to induce expression of the Git1 transporter for GPC uptake. 
Cultures were allowed to grow to logarithmic phase, harvested and the cell pellets were treated 
with 5% trichloroacetic acid (TCA) for 20 min on ice. Following centrifugation, the supernatant 
was discarded and cell pellets were incubated at 60°C for 60 minutes with 1 ml of ESOAK (95% 
ethanol, diethylether, H2O, pyridine, NH4OH (28-30%); 15:5:15:1:0.036 v/v/v/v). The tubes were 
centrifuged to pellet the debris and 1 ml of lipid-containing supernatant were transferred to fresh 
tubes containing 2.5 ml of chloroform/methanol (2:1) and 0.25 ml of 0.1 M HCl. Following 
vortexing and low speed centrifugation, the bottom layers containing glycerophospholipids were 
dried under N2. Lipids were then suspended in chloroform/methanol (2:1), spotted onto Silica Gel 
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TLC Plates (Whatman, Millipore Sigma 105626) and plates were developed in 
chloroform:methanol:acetic acid:water; (85:15:10:3.5 v/v/v/v) [50]. The TLC plates were imaged 
using a Typhoon 8200 phosphor imager. For Fig. 2B, image quant software was used to quantitate 
the PC and LPC spots. For Fig 2A, no LPC was detected, allowing the radioactivity (CPM) in the 
lipid fraction to be converted to pmole PC/ODU based on the specific activity of the exogenous 
label. 
For the experiments aimed at detecting LPC (Fig 2B), strains containing either empty 
vector or ADH-GIT1 [102] were grown in YNB inositol-free medium containing 5 μM of 14C-GPC 
(200,000 cpm/ml) and a standard level of KH2PO4. Cultures were inoculated at an A600 of  0.2 
from startup cultures. Cultures were allowed to grow for 4 h before harvesting  3.2 ODU’s of 
cells for each strain. Lipid extraction, separation and quantitation were as described in previous 
paragraph. LPC and PC standards (Avanti Polar lipids) were used to verify lipid migration on the 
TLC plates. Radiolabeled GPC was purchased from ARC, unlabeled GPC from Sigma Scientific. 
 
3.3.5. Analysis of PC and PE molecular species profiles by mass spectrometry  
The indicated strains were grown to logarithmic phase and 30 ODUs of each were 
harvested. The cell pellets were suspended in 2 ml of 5% TCA, followed by a 15 min incubation 
on ice. After centrifugation, the cell pellets were washed with 20 ml of Nano-pure H2O. 
Phospholipids were extracted from the pellet as described above and were finally resuspended in 
500 μL of CHCl3: MeOH (1:1, v/v). A 5 μL lipid sample was injected into an Agilent 1200 HPLC 
system coupled to an Agilent 6460 triple quadrupole LC/MS system. Lipid separations were 
performed on a Varian PLRP-S (150 X 2.1 mm, 5 μm) column at a flow rate of 0.35 ml/min and 
the column was maintained at 50C. Samples were eluted with a linear gradient using of 75% 
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methanol in water (A) and 100% methanol (B). Both solvents contained 10 mM ammonium acetate 
and 0.1% formic acid. Electrospray ionization-MS was performed with scanning mode set to 
multiple reaction monitoring set at m/z 184.1 product ion to detect PC molecules. PE species were 
detected by neutral loss scanning at 141 amu in positive ion mode. The MS parameters were 
optimized at: collision energy, 25 eV for PC and 15 eV for PE; capillary voltage 3500 V; 
fragmentor voltage, 100 V; dwell time, 200 ms; drying gas temperature, 320oC; sheath gas 
temperature, 350 oC; sheath gas flow, 11 liters/min and drying gas flow, 10 liters/min. Data were 
acquired and analyzed using Agilent Mass Hunter Work Station software. Reported values for 
various PC and PE species were corrected for isotope effect [105]. 
 
3.3.6. Analysis of PI and PS molecular species profiles by mass spectrometry 
Total lipid extracts were dissolved in CHCl3: MeOH 1:1 and injected in a UHPLC system 
equipped with a Kinetex HILIC column (50x4.60mm, 2.6 µm; Phenomenex, Utrecht, NL) with a 
SecurityGuard ULTRA HILIC precolumn. Lipids were eluted using a binary gradient of 
acetonitrile:acetone 9:1 (v/v) (with 0.1% formic acid; Eluent A) and 50 mM ammonium formate 
in acetonitrile:H2O 7:3 (v/v) (with 0.1% formic acid; Eluent B). The linear gradient was from 100% 
A to 50% A in 1 min, followed by isocratic elution at the latter composition for an additional 2 
min before a 1 min cleaning of the column with 100% B. Flowrate throughout the analysis was 1 
ml/min. MS analysis was performed on an LTQ-XL mass spectrometer (Thermo Scientific) using 
electrospray ionization (ESI) and detection in the negative mode (source voltage -4.2 kV). Full-
scan mass spectra were recorded over a range of 450-950 m/z. Data were converted to mzML 
format and analyzed using XCMS version 1.52.0 [106] running under R version 3.4.3, including 
isotope correction.  
 64 
 
 
3.3.7. Analysis of acyl chain composition 
Total cellular acyl chain composition was analyzed as described previously [36]. Briefly, 
total lipid extracts corresponding to 100 nmol phospholipid phosphorus were dried, and 
transesterified in methanolic H2SO4 (40:1 v/v) at 70°C. Fatty acid methyl esters (FAME) were 
extracted with hexane and separated on a Trace GC (Interscience, Breda, NL) equipped with a 
biscyanopropyl-polysiloxane column (Restek, Bellefonte, PA). FAME were identified, and signal 
intensity was calibrated using a commercially available standard (Nu-Chek, Elysian, MN). Acyl 
chain compositions are presented as mol% of total FAME recovered. 
 
3.3.8. RNA Extraction and Real-Time Quantitative RT-PCR (qRT-PCR) 
RNA was extracted from logarithmic phase cells using the hot phenolic RNA extraction 
protocol [107]. The extracted RNA sample was quantified using Thermo Scientific NanoDrop UV-
visible spectrophotometry.  Dnase treatment was performed on 7 μg of RNA using the TURBO 
DNA-freeTM kit (Applied Biosystems) as per the manufacturer’s protocol. The VersoTM SYBR 
Green 1-step QRT-PCR ROX kit (Thermo Scientific) was used to determine the message levels 
on an Applied Biosystems StepOne-PlusTM real-time PCR thermocycler.  The primer nucleotide 
sequence sets used in these studies are shown in Table 3. The optimal primer concentration (70-
100 nM) and template concentration (100 ng/25 μL reaction) were determined by performing a 
standard curve on each primer set. Reverse transcription was performed at 50°C for 15 min 
followed by 95°C for 15 min for RT inactivation and polymerase activation. The thermal profile 
for amplification were: 40 cycles at 95°C for 15 s, 54.5°C for 30 s and 72°C for 40 s [88]. Primer 
set specificity was determined by melting curve analysis. A no template control and a no RT 
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control were used to validate the absence of contaminants in RNA samples. Experiments were 
performed using 3 independent biological replicates and each replicate was analyzed in 
experimental triplicates. The data were normalized to the endogenous control gene, SNR17, and 
analyzed by the ΔΔCt method and [108, 109].    
 
3.3.9. Protein Extraction and Western Blot Analysis 
For figure 7a, cells were grown in YNB medium containing or lacking 75 μM of inositol. 
Cultures corresponding to 25 ODU’s of cells were harvested at log phase. The cell pellet was 
resuspended in ice cold extraction buffer (120mM NaCl, 50mM Tris-HCL (pH 7.5), 2mM EDTA, 
1mM PMSF, 1% NP-40, 0.1% SDS and 1% Triton X-100) containing 1x Yeast/ Fungal Protease 
Arrest TM mixture (G-Biosciences catalog no. 786-333). Lysis was performed using glass bead for 
8 cycles of the following: 30 seconds of vortexing and 30 seconds of incubation on ice. The cell 
debris was pelleted by centrifugation at 2000X g for 5 min.  
For figure 3. 9, cells were grown in YNB medium lacking inositol. Equivalent ODU’s of 
cells were harvested at log and stationary (24 hours) and late stationary phase (48 hours). Cell were 
lysed for 10 min on ice with 50 μL extraction buffer (0.2 M NaOH, 0.2 % mercaptaethanol) 
containing 1x Yeast/ Fungal Protease Arrest TM mixture (G-Biosciences catalog no. 786-333). 
Proteins were precipitated with 50 μL of 50% TCA and pelleted at 12,000 x g for 5 min. The 
pellets were suspended in 120 μL of dissolving buffer (4% SDS, 0.1 M Tris hydrochloride pH6.8, 
4mM EDTA, 20% glycerol, 2% 2-mercaptaethanol, 0.02% bromophenol blue)[110]. 
Samples were heated at 37C for 15 min. Protein in the supernatant was quantified using 
the Bradford assay kit (Thermo Fisher). An equivalent amount of protein was added to each lane. 
Western blot analysis was performed as described in [52]. Mouse monoclonal anti-HA (Sigma-
 66 
 
Aldrich, Cat no. H3663) was used as primary antibody, and goat anti-mouse antibody (LI-COR, 
cat no. 925-32210) was used for detection. The G6PD was used as the loading control [52].  
 
3.3.10. Re-cultivation from a Stationary Phase Culture 
Indicated strains were grown in YNB medium lacking inositol. Cultures were restarted at 
an A600 0.005 and growth curves were determined by measuring optical density at 600 nm (A600) 
as described previously for 4 days (all data points not shown). The ability to grow following re-
cultivate was examined by restarting the cultures at A600 0.005 from day 3 and day 4 of the 
cultures used in the growth curve. The stationary phase was confirmed by microscopy, where most 
cells were in the unbudded G0 phase. Growth of the re-cultivated cultures was monitored at three 
different time points.      
3.3.11. Statistical analysis 
 Paired t-test analysis or 2-way anova was performed to establish significances using 
GraphPad Prism 6.   
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3.4. Results  
3.4.1. GPC can be hydrolyzed by Gde1 or acylated by Gpc1 
PC remodeling through PC-DRP is indicated by red arrows. PC-DRP includes deacylation of PC 
to GPC by PLB1 or NTE1 followed by step-wise reacylation of GPC to LPC by GPC1 and LPC 
to PC by ALE1. The de novo PC synthesis routes are indicated by dotted arrows. Abbreviations: 
FA, fatty acid; G3P, glycerol 3-phosphate; DAG, diacylglycerol. Gpc1 starts by acylating GPC. 
 
Cellular GPC has two potential metabolic fates. The glycerophosphodiesterase encoded by 
GDE1 can hydrolyze GPC to produce glycerol-3-phosphate and choline [31, 97]. Additionally, 
GPC can be acylated (likely at the sn-1 position) to LPC by Gpc1, a recently described 
acyltransferase [52]. LPC can be converted to PC by Ale1, consistent with its role as a 
lysophospholipid acyltransferase [39, 40]. To gain further insight into the relative flux of GPC 
towards hydrolysis versus acylation, in vivo metabolic labelling was employed in strains lacking 
GPC1 and/or GDE1 (Fig. 3.2). Cells were grown in the presence of [14C] -GPC, which enters 
through the Git1 transporter [29, 30, 111], and label incorporation in the lipid fraction was 
determined.  
 
Figure 3. 1. Schematic outline of PC metabolism in yeast. 
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The [14C]-LPC intermediate in the acylation of [14C]-GPC to [14C]-PC is virtually 
undetectable under the uniform labeling conditions employed in Fig 3.2 A, therefore only the label 
in PC is quantified. As shown in Fig 3.2 A, a gpc1 mutant incorporates roughly 35% less label 
into PC as compared to wild type, consistent with its role as a GPC acyltransferase. A gde1  
mutant incorporates 50% less label into PC, indicating that a large portion of the label incorporated 
into PC in a wild type strain under low phosphate conditions originates from free [14C]-choline 
released through the action of Gde1. A gde1gpc1 double mutant incorporates even less label, 
confirming the importance of both metabolic routes in determining the ultimate fate of GPC. The 
label remaining in the gde1gpc1 double mutant is likely the result of an uncharacterized 
acyltransferase and/or glycerophosphodiesterase that can act on GPC.  
 
3.4.2. Gpc1 and Ale1 are central players in the step-wise acylation of GPC to lysoPC and 
then to PC 
To demonstrate that Gpc1 produces LPC in vivo, and thereby confirm its cellular role, we 
designed an alternative labeling scheme and employed an ale1 mutant to block the second 
acylation step (Fig 3.2 B). In the experiment represented in Fig 3.2 A, cells were grown under low 
phosphate conditions in order to induce the expression of GIT1 [111], a condition that also induces 
the expression of GDE1 [31, 32]. Here, a plasmid harboring GIT1 under the control of the 
constitutive ADH1 promoter [102] was employed to allow cell growth under normal phosphate 
level, a condition that represses the expression of GDE1 and, therefore, reduces the hydrolysis of 
GPC once it enters the cell [31, 32]. In addition, the labelling time in the presence of [14C]-GPC 
was reduced to roughly 2 generations. Under these conditions, a 3-fold increase in labeled LPC 
was detected in an ale1 mutant as compared to wild type, and that increase was counteracted by 
 69 
 
simultaneous deletion of GPC1 (see the ale1gpc1 double mutant). At the same time, labeled 
PC levels decreased in an ale1 mutant and decreased further in an ale1gpc1 double mutant. 
The fact that PC levels were reduced by only 50% in the ale1 strain suggests that other enzymes 
may exist that are capable of converting LPC to PC in the cell. However, an additional possibility 
is that the increased LPC being produced is hydrolyzed, ultimately releasing free choline that could 
be incorporated into PC via the Kennedy pathway. These results confirm the formation of the 
immediate product of Gpc1 activity, LPC, in vivo, and the role of Ale1 in converting LPC into PC. 
A. The indicated strains were grown to log phase in the presence of 5M [14C]choline-GPC. Cells 
were harvested, phospholipids were extracted and separated, and PC was quantified as described 
in Experimental Procedures. B. Indicated strains contained plasmid in which GIT1 was 
constitutively expressed under the control of the ADH1 promoter. Cells were grown in the presence 
of [14C]choline-GPC for 4 hours, harvested, and phospholipids were extracted and analyzed as 
described in Experimental Procedures.  The data is normalized to the wild type (WT) containing 
ADH1-GIT1. Roughly 100-fold more PC was detected as compared to LPC in the wild type strain. 
Data represent average of 3 independent cultures ± SD. A t-test was performed to determine 
significance as indicated. (*p value value  *0.05, **0.005, ***0.0005). 
Figure 3. 2. The role of Gpc1 in PC metabolism. 
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A, B, The indicated strains were grown to late log phase, cultures were harvested, and lipids were 
extracted. PC species were separated and analyzed using LC- MS/MS, as described in 
Experimental Procedures. Data represent average of 3 independent cultures ± SD. A t-test was 
performed to determine significance as indicated (*p value  0.05).  
 
3.4.3. Gpc1 impacts the PC molecular species profile 
 A potential function for the PC-DRP is to modify the acyl chain content. In order to 
determine if Gpc1 activity affects the PC molecular species profile, LC-MS/MS was performed 
(parent ion scanning for m/z 184). Cells were not supplemented with exogenous GPC for these 
experiments, so the substrate for Gpc1 activity presumably arose through endogenous 
phospholipase B activity [97]. Fig. 3.3A includes the range of PC species produced by yeast. 
Figure 3. 3. Gpc1 impacts PC molecular species profile. 
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Focusing on the major species, the data indicate that the loss of Gpc1 results in a decrease in mono-
unsaturated PC species (32:1, 34:1) and an increase in di-unsaturated PC species (32:2, 34:2) as 
proportions of the total PC pool. Overexpression, as predicted, has the opposite effect (Fig. 3.3B). 
When GPC1 was placed under the control of the GAL1 promoter and cells were grown on galactose, 
there was an increase in mono-unsaturated PC species (32:1 and 34:1) and a decrease in di-
unsaturated PC species (32:2, 34:2). In total, these results indicate that Gpc1 impacts the PC 
species profile and suggest that Gpc1 activity favors the utilization of saturated acyl-CoA species 
when acylating GPC. 
 
3.4.4. Loss of Pct1 and Ale1 have minor effects on the PC species profile 
 Since Ale1 converts LPC to PC as part of the PC-DRP, we analyzed its impact on the PC 
molecular species profile. If Ale1 were the only LPC acyltransferase in the cell, and assuming that 
Ale1 does not affect the species profiles of the lipid precursors of PC (PE and DAG), the profile 
of the ale1 mutant should resemble that of the gpc1 mutant, as the reacylation pathway would 
stall at LPC, and the LPC produced would likely be rapidly hydrolyzed by phospholipases. In fact, 
the ale1 mutant did not resemble the gpc1 strain in terms of PC species, as a slight decrease in 
PC32:2 and an increase in PC34:2 were its only significant changes from WT.   The ale1 gpc1 
mutant, like gpc1, exhibited an increase in di-unsaturated species and a decrease in mono-
unsaturated species as compared to WT, although the magnitude of the changes was not identical 
between the two strains (Fig. 3. 4). These results suggest that there may be more acyltransferases 
capable of acylating lysoPC in the cell [33, 37]. 
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The indicated strains were grown to late log phase, cultures were harvested, and lipids were 
extracted. PC species were separated and analyzed as described in Experimental Procedures. Data 
represents average of 3 independent cultures ± SD. A 2-way ANOVA was performed to determine 
significance for each strain compared to the WT (*p value  *0.05, **0.004, ***0.0001).   
 
The steady state PC molecular species profile in a cell represents a combination of PC biosynthesis, 
PC degradation and PC acyl chain remodeling. In the experiments presented in Fig. 3. 3, cells were 
grown in the absence of free choline, so the PE methylation pathway, not the Kennedy pathway, 
was primarily responsible for PC biosynthesis. However, flux through the Kennedy pathway can 
also occur as a result of free choline released through phospholipase-mediated turnover. In order 
to examine the extent to which PC turnover resulting in free choline release followed by re-
synthesis contributes to the observed PC species profile, we utilized a pct1 mutant in which flux 
through the Kennedy pathway is blocked. As shown in Fig 3. 4, the PC species profile in pct1 
was largely unchanged from wild type (in agreement with ref 20), but did result in a small but 
Figure 3. 4 Loss of PCT1 or ALE1 has minor effects on PC species profile. 
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significant increase in 32:1 PC. That increase may be the result of the observed uptick in GPC1 
transcript upon PCT1 deletion (forthcoming Fig. 3. 6), as evidenced by the fact that 32:1 again 
decreases in a pct1gpc1 double mutant. Overall, these results indicate that the PC species 
profiles generated under our experimental conditions are primarily the result of PC synthesis via 
the PE methylation pathway followed by PC remodeling via PC-DRP.  
 
3.4.5. Loss of Gpc1 does not affect PE, PI, PS species profiles and slightly decreases total 
16:0 FA content 
  We reported previously that Gpc1 had limited ability to utilize acyl-CoAs to acylate 
glycerophosphoethanolamine (GPE) in an in vitro system [52]. To probe the possibility that Gpc1 
acylates GPE to affect PE in vivo, we analyzed the PE molecular species. As shown in Fig. 5A, we 
did not detect any significant difference in PE molecular species profile when comparing a wild 
type strain to a gpc1 strain. Hence, Gpc1 does not play a major role, if at all, in PE remodeling 
in vivo under the conditions employed here. 
The effect of GPC1 deletion on the phosphatidylinositol (PI) and phosphatidylserine (PS) 
species profiles was also examined. As shown in Figs. 3. 5B and 3. 5C, no significant differences 
between wild type and gpc1 were found. In addition, the overall fatty acid composition of all 
cellular lipids was determined by gas chromatography. As shown in Fig. 3. 5D, WT and gpc1  
fatty acid compositions are largely the same, with the exception of a small but significant decrease 
in C16:0 in gpc1. This change is consistent with the fact that the gpc1  mutant displays a 
decrease in monounsaturated PC species and may reflect the loss of a small C16:0 sink resulting 
from the inability of gpc1 to add C16:0 to GPC during the PC remodeling process. The results 
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indicate that loss of GPC1 does not induce large-scale changes in fatty acid composition, but rather 
highly specific effects.  
 
A, B, C, D. The indicated strains were grown to log phase, harvested, and lipids were extracted. 
A, B, C. PE, PS and PI species were analyzed by MS as detailed in Experimental Procedures. D. 
Total acyl chain composition was determined using gas chromatography. Data represent average 
of 4 independent cultures ± SD A t-test was performed to determine significance as indicated (*p 
value= 0.0008). 
 
Figure 3. 5. Loss of GPC1 has no significant effects on PE, PS, PI species profiles and 
slightly decreases the total C16:0 acyl chain content. 
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3.4.6. GPC1 expression is upregulated by attenuation of PC biosynthesis and by inositol 
limitation  
To gain further insight into the physiological role of Gpc1, we examined its transcriptional 
regulation in response to alterations in major lipid biosynthetic pathways. To examine PC 
biosynthesis, we employed a cho2 mutant (attenuated PE methylation pathway), a pct1 
mutant (blocked Kennedy pathway), and a cho2 pct1 mutant. The PE methylation pathway for 
PC biosynthesis is not completely blocked in the cho2 pct1  double mutant, due to a partially 
redundant function supplied by the methyltransferase, Opi3 [19]. As shown in Fig. 3. 6a, GPC1 
message levels, as measured by qRT-PCR, are increased roughly 3-fold in each single mutant 
and in the double mutant as compared to wild type. Thus, inhibition of either pathway for PC 
biosynthesis causes an increase in GPC1 message, but the effect is not additive. 
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A, B. The indicated strains were grown to log phase, cells were harvested, and RNA was extracted. 
GPC1 transcripts were quantified by qRT-PCR. Data was normalized to the amount of the 
endogenous control mRNA, SNR17, and expressed relative to the wild type (WT) strain. B, Wild 
type grown in the presence of 75 M inositol (WT+Inositol) compared to wild type grown in the 
absence of inositol (WT-Inositol). Experiments were performed in biological triplicates and 
assayed in experimental triplicate. A t-test was performed to establish significance (*P  **0.005, 
***0.0005). 
 
Figure 3. 6. GPC1 transcript is increased by attenuation of PC and by inositol limitation. 
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A number of phospholipid biosynthetic genes are regulated by the presence of inositol in the 
medium via a complex mechanism involving the modulation of PA levels at the ER, which in 
turn impacts the transit of the Opi1 repressor protein into the nucleus [22, 112]. Thus, inositol 
availability has a general impact on phospholipid composition and flux through the various 
pathways [5, 22]. As shown in Fig 3. 6B, there is a roughly 5-fold decrease in GPC1 message 
upon inositol supplementation 
A. WT strain was grown in medium containing 75 M inositol (+Inositol) or lacking Inositol (-
Inositol). Western blot analysis was performed using anti-HA Mouse IRdye 680 and Goat 
antimouse IRdye 800. Glucose-6-phosphate dehydrogenase was used as loading control. Protein 
bands were quantified using Image StudioTM software. Data represents 2 biological replicates.  B. 
The indicated strains were grown to late log phase before harvesting. Phospholipids were extracted, 
and PC species were analyzed using LC-MS/MS. Data represent average of 3 independent cultures 
± SD. A t-test was performed to establish significance (*P  ****0.0005) C. Strains were cultured 
in synthetic medium, harvested and resuspended in sterile water. 10-fold serial dilutions (5 l) 
were spotted onto plates containing (+Inositol) or lacking (-Inositol) inositol.  
 
Figure 3. 7.  Inositol supplementation affects Gpc1 protein level and PC species profile. 
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A. Indicated strains were grown in synthetic liquid medium lacking inositol and growth was 
monitored by measuring optical density at OD600 over 40 hours. The cultures (A) were allowed to 
continue shaking at 30°C until day 4 (roughly 96 hours). B. On Day 3 and Day 4, cells were taken 
from the original cultures and inoculated in fresh YNB I- medium to an A600 of 0.005.  OD600 was 
determined at 24, 29, 32 hrs. Experiments were performed with 3 biological replicates, all data 
points not shown.  
 
 
3.4.7. Inositol supplementation represses GPC1 expression and increases di-unsaturated PC 
species 
 Following the qRT-PCR findings (Fig. 3. 6) the effect of inositol availability was 
examined more thoroughly, as this perturbation produced the largest transcriptional response, and 
would not confound the interpretation of the PC species profile by impacting PC biosynthesis (as 
Figure 3. 8. Loss of GPC1 impacts growth and stationary phase viability in inositol free 
medium.  
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would the cho2 and cho2pct1 mutants). As seen in Fig. 3. 7A, the decrease in GPC1 transcript 
upon inositol supplementation, was reflected in a decrease in Gpc1 as measured by Western 
analysis. It should be noted that the PC species profiles presented in Fig. 3 were performed on cells 
grown in the absence of inositol (I-) in order to maximize GPC1 expression. When grown in the 
presence of inositol (I+), there is a clear increase in diunsaturated PC species and a clear decrease 
in monounsaturated PC species (Fig. 3. 7B) in a wild type strain, similar to the effect of GPC1 
deletion (Fig. 3. 3A and Fig. 3. 7B) in I- medium. A similar pattern of changes in PC molecular 
species profile upon inositol limitation was reported previously [20]. Loss of Gpc1 and inositol 
supplementation together result in an even greater increase in di-unsaturated species, indicating 
that factors beyond Gpc1 are at play in impacting the PC species profile under these conditions.   
 
3.4.8. Loss of Gpc1 impacts growth and stationary phase viability in inositol free medium 
Growth assays were performed to assess the phenotypic consequences of diminished PC 
remodeling as a function of inositol availability. In the absence of inositol, where GPC1 expression 
is upregulated, there is a small but significant growth defect on plates (Fig. 3. 7C), which is not 
consistently seen in I+ conditions. To explore this finding further, we monitored growth in liquid 
culture under I- conditions. As shown in Fig. 3. 8A, gpc1 mutants displayed an increase in lag 
time resulting in slower growth overall, although the rate of doubling during logarithmic phase 
was comparable to wild type.  
To determine if decreased ability of cells to regrow from stationary phase was the reason 
behind the increased lag time, a re-cultivation experiment was performed. Cells were grown to 
stationary phase (as in Fig 3. 8A) but the cultures were incubated longer, for a total of 4 days. On 
days 3 and 4, cells were taken from the original cultures and inoculated in fresh YNB I- medium. 
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By day three, gpc1  lagged well behind wild type in its ability to reinitiate growth as measured 
at three time points over 32 hours (Fig. 3. 8B; Day 3).  In four day old cultures, no growth was 
detected in the gpc1  cultures as measured over 32 hours (Fig. 3. 8C; Day 4).  These results 
indicate that loss of Gpc1 results in a loss in stationary phase viability in inositol-free medium. 
Western blot analysis was performed to examine Gpc1 protein levels as a function of growth phase. 
While Gpc1 was found to be expressed in logarithmic phase (Fig 3. 9),  little or no expression was 
detected in stationary phase (24 and 48 hours of growth). This finding suggests that no further 
remodeling of PC via this pathway occurs once the cells reach stationary phase.  
 
 
WT strain was grown in medium lacking Inositol. Cultures were harvested at log (14 h), early 
stationary (24 h) and late stationary (48 h) phases. Western blot analysis was performed using anti-
HA Mouse IRdye 680 and Goat antimouse IRdye 800. Glucose-6-phosphate dehydrogenase was 
used as loading control.  
 
3.5. Discussion 
PC metabolism consists of interconnected pathways of synthesis, degradation, recycling of 
catabolites, and remodeling (Fig. 3. 2A). Deacylation of PC via phospholipases of the B type 
Figure 3. 9. Gpc1 is highly expressed in logarithmic phase. 
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produces GPC. Our previous studies have shown that GPC is found both intracellularly and 
extracellularly and that it can be transported into the cell via the Git1 permease [30, 31]. A well-
characterized pathway for GPC degradation is its hydrolysis to choline and glycerol-3-phosphate 
by the glycerophosphodiesterase, Gde1 [31, 96]. Prior to the identification of GPC1, GPC 
acyltransferase activity had been detected in Xanthomonas campestris, S. cerevisiae and plants 
[49-51]. Our recent identification of the gene encoding Gpc1 provided a tool for examining the 
relative flux of GPC between degradation versus acylation. When considering the label 
incorporated into PC from exogenous GPC, roughly 50% occurs via Gde1 activity producing free 
choline that is subsequently utilized by the Kennedy pathway.  Roughly 30% is acylated by Gpc1, 
and another 20% is presumably metabolized by unknown enzymes. Thus, reacylation is not a 
trivial pathway for GPC conversion to PC. Through the use of mutants and radiolabeling (Fig. 3. 
2 B) the primary roles of Gpc1 and Ale1 in the stepwise conversion of GPC to PC as part of the 
PC-DRP were confirmed.  
 
Although the acylation of GPC to PC clearly occurs in the cell, the synthesis of PC at a 
level that supports growth requires either a functional PE methylation pathway or a functional 
Kennedy pathway [6] [58]. Hence, we hypothesized that the primary purpose of GPC reacylation 
may not be bulk synthesis, but rather the synthesis of specific PC species as part of a remodeling 
pathway. Evidence for post-synthetic PC remodeling in yeast has been described by multiple 
research groups [55] [57, 58, 113, 114]. Importantly, De Kroon and colleagues have used stable-
isotope pulse-chase analysis coupled with MS to prove the post-synthetic formation of more 
saturated PC species as a function of time, and demonstrated the involvement of Plb1 [60]. Prior 
to the identification of Gpc1 activity [49, 52], PC remodeling was believed to involve the removal 
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of a single acyl chain at the sn-2 position, followed by reacylation by a LPC acyltransferase 
(LPCAT), a cycle first described by Lands [115]. Once LPC is formed, it can be acylated to PC by 
Ale1 [39, 40, 116], with some publications indicating that Ale1 prefers incorporation of an 
unsaturated acyl-CoA species at sn-2 position of 1-acyl LPC [39, 41, 116-118]. A recent 
publication has provided evidence that Ale1 may also have limited ability to acylate the sn-1 
position of the synthetic LPC analog, 2-alkyl-sn-glycero-3-phosphocholine [114]. Importantly, we 
posit that the previous step in the remodeling pathway, the acylation of GPC, is carried out by the 
glycerophosphocholine acyltransferase (GPCAT) activity of Gpc1, adding another dimension to 
the process of PC remodeling, namely the potential exchange of both acyl chains. Of course, this 
finding does not preclude the possibility of PC remodeling occurring via other acyltransferase or 
transacylase activities [33, 37]. PC molecular species profiling of cells lacking GPC1 (Fig. 3. 3A) 
or overexpressing GPC1 (Fig. 3. 3B) clearly indicates that Gpc1 impacts the PC species profile, 
producing a higher content of more saturated PC species (32:1 and 34:1) when present. The impact 
of Gpc1 on phospholipid molecular species is limited to PC, as PI, PE, and PS species profiles are 
unchanged by loss of Gpc1.  
 
The obvious general question arising from these results is under what circumstances is 
Gpc1 activity and PC remodeling beneficial? The PC molecular species profile is highly dynamic 
[119, 120]. Given that changes in PC saturation status may well affect a membrane property such 
as fluidity, we reasoned that Gpc1 must be co-regulated with regards to other lipid metabolic 
processes to maintain optimal bilayer function. As a first approach, we utilized qRT-PCR to assess 
changes in transcript levels by attenuating the methylation pathway (cho2) or blocking the 
Kennedy pathway (pct1) either singly or in combination results in an uptick in GPC1 message 
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levels. Granted, this experiment does not have a straightforward interpretation, as the inhibition of 
the major PC biosynthetic pathways may cause an increase in GPC reacylation as an end towards 
preserving PC, not remodeling PC. By similar reasoning, we did not test the effects of choline 
supplementation in this study (but will be examined in future studies), as that perturbation would 
increase biosynthesis through the CDP-choline pathway, potentially obscuring the interpretation 
of the findings. Nonetheless, our results clearly show that GPC1 message increases upon inhibition 
of PC biosynthesis. 
 
Inositol availability has far-reaching transcriptional and physiological effects in yeast. 
Inositol is required for PI biosynthesis. In turn, PI is a precursor for phosphoinositides, 
polyphosphates, inositol sphingolipids, and GPI anchors [5, 20, 22]. Inositol can be synthesized 
by the cell and/or imported into the cell from the medium [121]. In the absence of exogenous 
inositol, a number of genes involved in phospholipid metabolism are transcriptionally induced [5, 
22]. Inositol supplementation results in a 5-fold downregulation of GPC1 message, and a 3-fold 
decrease in protein level (Figs. 3. 6B and 3. 7A). Downregulation of GPC1 transcript and protein 
levels by inositol supplementation resulted in changes in the PC species profile, providing an 
explanation for a similar result reported by Henry and colleagues  [20] prior to the identification 
of Gpc1.  
 
Most genes responsive to inositol limitation contain one or more UASINO elements 
(consensus sequence 5'CATGTGAAAT3') in their promoters and are regulated by Ino2, Ino4, and 
Opi1 via the Henry Regulatory Circuit [21, 22, 122]. The transcription factors, Ino2 and Ino4, 
typically bind to UASINO as a heterodimer to activate transcription when inositol is limiting, and 
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the Opi1 repressor binds to Ino2 to block transcriptional activation when inositol is available. The 
Gpc1 promoter contains a sequence (CTTGTGAATA) that is 3 base pair off from the consensus 
Ino2:Ino4 binding sequence [123] at -193 to -202. In addition, it contains a site (CATTTG) for 
Ino4-dependent/Ino2-independent binding [124] at -182bp to -187bp. Further evidence for control 
by the Henry Regulatory Circuit is provided by microarray studies performed prior to the 
characterization of Gpc1 in which Opi1 [125] and Ino4 [126] were shown to affect transcription 
of the GPC1 ORF, YGR194w. Further studies would be required to unequivocally prove binding 
of Ino2 and/or Ino4 to the GPC1 promoter. 
 
In medium lacking inositol, where GPC1 is upregulated, gpc1 mutants display decreased 
stationary phase viability (Fig. 3. 8). However, we did not detect Gpc1 expression in stationary 
phase, suggesting that the alteration in PC species that occurs via PC-DRP during log phase may 
prepare the membrane for events that occur in later stages of growth.  Gpc1 is predicted to be an 
integral membrane protein with 8 transmembrane domains [52].  A definitive localization study 
has not been performed for Gpc1, but will be the focus of future studies and may shed light on its 
role in cell viability. Of note, the changes in lipid metabolism resulting from I- medium are 
accompanied by the induction of multiple stress response pathways, including the Unfolded 
Protein Response (UPR), the PKC-MAPK pathway, and others [22]. Thus, the loss of cell viability 
observed under I- conditions upon loss of GPC1 is likely the result of a complex series of events.  
 
In summary, our data indicate that Gpc1 is part of a novel PC deacylation/reacylation 
remodeling pathway (PC-DRP) that provides the opportunity for post-synthetic alteration of both 
acyl chains species and, thereby, to impact the biophysical properties of the membrane.  
 85 
 
 
Acknowledgements 
 This work was supported, in whole or in part, by National Institutes of Health Grant R15 
GM 104876 (to J.P.-V.), PlantLink and the Strategic Research Area project “Trees and Crops for 
the Future (to I.L.) and The Netherlands Organization for Scientific Research (NWO) (to M.R. 
and A.deK). The purchase of mass spectrometers was supported by National Science Foundation 
Grant MRIDBI-0821401 to Duquesne University. The authors thank Dr. Amrah Weijn for help 
with the MS sample preparation. 
 
  
 86 
 
Table 1 
S. cerevisiae strains used in this study 
 Strain Genotype Reference 
JPV 399 
JPV 788 
JPV 125 
JPV 834 
JPV 272 
JPV 839 
JPV 841 
JPV 269 
JPV 270 
JPV 832 
JPV 833 
JPV 846 
WT, BY4742 
gpc1Δ 
gde1Δ 
gde1Δ gpc1Δ 
cho2Δ pct1Δ 
cho2Δ pct1Δ gpc1Δ 
pct1Δ gpc1Δ 
cho2Δ 
pct1Δ 
ale1Δ 
ale1Δ gpc1Δ 
WT+GPC1-3xHA 
BY4742; MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 
BY4742; gpc1::KanMX 
BY4742; gde1::KanMX 
JPV 125; gpc1::URA3 
BY4742; cho2:: KanMX pct1:: LEU2 
JPV 272; gpc1::URA3 
JPV 788; pct1:: LEU2 
BY4742; cho2::KanMX 
BY4742; pct1:: LEU2 
Mat a:  his3∆1 leu2Δ0 met15∆0 ura3∆0 ale1::KANMX 
JPV 832; gpc1::KANMX 
BY4742; GPC1-3xHA 
Research Genetics 
This study 
This study 
This study 
This study 
This study 
This study 
Research Genetics 
Research Genetics 
[52] 
[52] 
This study 
 
Table 2 
Nucleotide primer sequences used for gene deletions 
The Bold sequences are homologous to the template plasmid. The deleted gene was replaced with gene 
name in parentheses.  
Gene name Primer Sequence (5’-3’) 
GPC1(URA3)  
GPC1(URA3) 
GPC1(LEU2) 
GPC1(LEU2) 
GPC1-1-3XHA 
GPC1-1-3XHA 
Forward 
Reverse  
Forward 
Reverse 
Forward 
Reverse 
ATGTACAAGTTGGACAATAACGACATTGACGATGAAACGAATAACTCTGTTTCACTGACG 
AGCGAACAAAAGCTGG 
CTTAATCACTCTTTGAGGATACACTTGAAGAGTCGTCAAAATCTTCGTCACGGTTGACAT 
CTGTAGGGCGAATTGGG 
ATGTACAAGTTGGACAATAACGACATTGACGATGAAACGAATAACTCTGTTTCACTGACG 
CACATACCTAATATTATTGC 
CTTAATCACTCTTTGAGGATACACTTGAAGAGTCGTCAAAATCTTCGTCACGGTTGACAT 
GAATCTTTTTAAGCAAGGAT 
TTGAATGTCAACCGTGACGAAGATTTTGACGACTCTTCAAGTGTATCCTCAAAGAGTGAT 
AGGGAACAAAAGCTGGAG 
GTAAAGCGCCTGTAAATAAAAGCTCTCAAAGTTAACAGATAAATGAAGTGAACTATCTTA 
CTGTAGGGCGAATTGGG 
 
Table 3 
Nucleotide primer sequences for qRT-PCR 
Gene name  Primer Sequence (5’-3’) 
SNR17 
SNR17 
GPC1 
GPC1 
Forward 
Reverse  
Forward 
Reverse  
TTG ACT CTT CAA AAG AGC CAC TGA 
CGG TTT CTC ACT CTG GGG TAC 
AAA TTA GCT GCG GCC CTA TT  
TAT CAT TCA CGG AGG CAT CA 
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Chapter 4: Summary and future directions 
4.1. Summary of novel findings 
 My dissertation work has increased our understanding of PC metabolism through the 
characteristics of Gpc1. The first major finding focused on identifying and determining the in vivo 
role of Gpc1. GPCAT homolog analysis revealed a wide distribution of homologs in eukaryotes 
including fungi, animal, plants, algae, and most protist clades. In a second major finding, I have 
determined the role of Gpc1 in a PC deacylation/reacylation remodeling pathway (PC-DRP).  
Membrane remodeling involving Gpc1 resulted in an increase in the monounsaturated PC species 
at the expense of diunsaturated PC species. PC remodeling through PC-DRP occurs by removal of 
both the acyl chains at the sn-1 and sn-2 positions of GPC by a phospholipase of the B-type 
followed by sequential reacylation by Gpc1 and Ale1. This process results in an increased level of 
saturated PC species. This process was found to be vital for cell viability at the stationary phase 
under inositol-free conditions. Also, inositol was found to be involved in downregulating the 
expression of GPC1. PC-DRP signifies a new aspect to PC metabolism. Given that plant homologs 
of Gpc1 have similar functions collectively, I expect these findings to improve our understanding 
of PC metabolism across multiple species. The following are some of the open questions and future 
directions that should be addressed.  
 
4.2. What is the impact of the PC-DRP pathway on the total PC synthesis? 
Yeast has two major pathways, i.e., the Kennedy and methylation pathways, for bulk PC 
synthesis. Either one is sufficient for cell survival upon disruption of the other. The PC-DRP 
pathway is an alternative route for PC synthesis in yeast, but it is crucial to know the impact of 
this pathway on total PC synthesis. 
 88 
 
This can be approached by performing a 32P-orthophosphate labeling in the WT and gpc1Δ 
strains grown in synthetic medium without the supplementation of GPC. The absence of 
exogenous GPC would force the cell to utilize the intracellular GPC that is produced by the action 
of Plb1. The 32P-orthophosphate would be incorporated in all phosphate containing molecules, 
including the phospholipids, in the cell. Potential changes in the level of PC upon deletion of gpc1Δ 
can be quantified as described in appendix A.5. I had initiated these studies (Figure A. 5) in WT 
and gpc1Δ containing empty vector or GAL1-GPC1 overexpressor, but it was performed in a single 
replicate. This experiment can be performed in biological replicates to get publication quality data. 
 
4.3. Is GPC1 expression regulated through the Henry Regulatory Circuit?  
I have documented the effect of inositol supplementation in downregulating GPC1 
expression. This downregulation could be due to the so-called Henry regulatory circuit that is 
known to regulate a number of phospholipid biosynthetic genes. Opi1, Ino2 and Ino4 are key 
transcription factors that play a crucial role in regulating the genes responsive to inositol limitation. 
There is evidence from microarray studies that were performed before the characterization of 
GPC1 [120,121] that suggest GPC1 expression might be controlled by Opi1 and Ino4 transcription 
factors. This could be verified by measuring GPC1 message levels in opi1Δ and ino4Δ strains. 
 
4.4. Does ethanol or reactive oxygen species (ROS) play a role for the decreased cell 
viability in stationary phase? 
We have documented that the inability to remodel PC results in loss of cell viability at the 
stationary phase. A possible reason for this loss could be due to the production of ethanol in 
stationary phase that may act as a membrane fluidizer. Remodeling the PC by Gpc1 would increase 
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the level of saturated PC species which could rigidify the membrane. Thus, Gpc1 might be crucial 
in sustaining viability at the stationary phase. Also, GPC1 expression is upregulated (Figure A. 10) 
when ethanol/glycerol was used as the carbon source instead of glucose. Overall, these results 
suggest that PC remodeling by Gpc1 could help in negating the effect of ethanol as the membrane 
fluidizer. This effect can be delineated by studying the growth pattern of WT and gpc1Δ strains 
upon supplementation of ethanol. I would expect the gpc1Δ strain to grow slower than the WT. A 
direct method of measuring fluidity, such as, by using lipophilic probe diphenylhexatriene (DPH) 
would be informative [127].   
Another possible explanation for the decreased cell viability could be due to the lipid 
peroxidation that is seen during stationary phase [128, 129].  The Remodeling of PC through PC-
DRP would increase the saturation state of PC and that could provide resistance against lipid 
peroxidation. Msn2 and Msn4 are transcription factors that are known to be involved in regulating 
the oxidative stress [130]. I have identified Msn2 and Msn4 stress response elements (-154bp to -
158bp) in GPC1 promoter that might be involved in regulating GPC1 [130]. The role of Msn2 and 
Msn4 in GPC1 expression can be examined by determining GPC1 message levels in msn1Δ and 
msn2Δ strains. A direct measure of lipid peroxides in WT and gpc1Δ by MDA assay [131] would 
also be informative. 
       
4.5. Is the ortholog of GPC1 from Candida albicans involved in PC biosynthesis? 
Candida albicans is an opportunistic fungal pathogen that is known for 1-2 million human 
deaths each year. We have identified ORF 19.88 (caGPC1) as the ortholog of GPC1 in C. albicans 
and predict that caGPC1 be involved in a similar novel route for PC biosynthesis. Also, our lab 
has recently shown that the inability to transport GPC into the cell is associated with decreased 
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virulence of Candida albicans. This suggests that this metabolite is essential for growth during 
infection [81].  
These studies can be initiated by constructing a gpc1Δ/gpc1Δ homozygous deletion strain 
and a heterozygous deletion strain by reintegrating a single copy of GPC1 into the homozygous 
mutant. This could be approached either by the traditional PCR-based gene deletion or by use of a 
CRISPR/ Cas9 system. The WT and the mutants can then be tested by performing in vivo metabolic 
labeling studies as described in chapter two to examine the role of the ortholog in PC biosynthesis.  
 
4.6. Is GPC1 expression affected by the addition of saturated or unsaturated fatty acids?  
Since GPC1 defines a PC-DRP that increases the saturation state of PC, it is possible that 
supplementation of saturated (16:0, 18:0) or an unsaturated (16:1, 18:1) fatty acids might have an 
impact on the GPC1 transcript, protein, activity or level. The impact on GPC1 transcript can be 
tested by growing WT in the synthetic medium supplemented with and without these fatty acids. 
The mRNA levels can then be quantified as described in Chapter three. These findings would 
provide us with an insight into the adaptation of GPC1 expression with regards to the changes in 
the FA content. The most exciting result from expression data can then be pursued by examination 
of Gpc1 protein levels by Western blot analysis. 
  
4.7. Is PC-DRP regulated with coordination to sphingolipid biosynthesis?                        
Sphingolipids are the second major class of membrane lipids. Sphingolipid biosynthesis 
can be inhibited by a drug named myriocin that blocks the serine palmitoyltransferase, Lcb1, to 
inhibit the de novo synthesis [132]. Given that sphingolipids are essential membrane components 
[133], it is not surprising that inhibition of their synthesis would result in changes to PC 
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metabolism. Our previous finding indicates that inhibition of sphingolipid biosynthesis results in 
an increase in the PLB1 message level and the expected increase in the GPC production [88]. In 
addition, I have identified that inhibition of sphingolipids synthesis results in upregulation of 
GPC1 expression in a WT strain (Fig A.8.a). An obvious question to explore is if PC deacylation 
by Plb1 and GPC reacylation by Gpc1 is regulated in coordination with the sphingolipid 
biosynthesis. This could be tested by examining the transcript levels of genes involved in PC-DRP 
(PLB1, NTE1, GPC1, and ALE1) upon perturbation of sphingolipids biosynthesis.  
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A. Appendix 
 
The following are notable experiments that were not published, either because they did not fit in 
the theme of a publication or were not performed with enough biological replicates. 
 
 
 
A. 1. Effect of phospholipase-B mutation on radiolabeled 3H-GPC incorporation into 
metabolities.  
A, B. WT, plb1, 2, 3Δ nte1Δ, and plb1, 2, 3Δ nte1Δ gpc1Δ strains with or without the EV or Gal1-
GPC1 plasmids were used in this study. Cultures were grown to log phase in synthetic medium 
lacking inositol and containing 200 M KH2PO4 and 5 M of choline (3H) -GPC. Cells were 
harvested and separated into the extracellular, intracellular and membrane fractions. The 3H label 
was quantified in all these fractions as described in chapter 2. A. The plb1, 2, 3Δ nte1Δ mutant 
showed an increase in the TCA fraction and a decrease in the membrane fraction when compared 
to the WT. Similar trends were seen for plb1, 2, 3Δ nte1Δ gpc1Δ. These results suggest that the 
inabilities in deacylation (plb1, 2, 3Δ nte1Δ) and deacylation/ reacylation (plb1, 2, 3Δ nte1Δ gpc1Δ) 
reduces the flux of 3H-GPC to 3H-PC. The experiment was performed in a single replicate. This 
penta-mutant was constructed for our collaborator, Dr. Ida Lager, for investigating the role of 
GPC1 under limited PC deacylation condition. 
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A. 2. Overexpression of GPC1 in strain attenuated for PC biosynthesis results in 
increased flux of 3H-GPC into the membrane fraction. 
WT and cho2Δ pct1Δ containing EV or Gal1-GPC1 plasmid were used in this study. Cultures 
were grown to log phase in synthetic medium lacking uracil, and containing 2% galactose, 5 M 
3H-GPC and 200 M KH2PO4. Cells were harvested and separated in fractions as described in 
chapter two. The cho2Δ pct1Δ has attenuation in two major pathways for PC biosynthesis. The 
overexpression of GPC1 in cho2Δ pct1Δ strain results in an increased flux of 3H-GPC from 
intracellular fraction into 3H-PC in the membrane fraction. Finally, overexpression of GPC1 in 
WT strain did not change the flux of 3H-GPC, as Gpc1 dosage may not be rate-limiting. The 
experiments were performed in biological triplicates. The experiment was performed in biological 
triplicate. A t-test was performed to determine significance as indicated (*p-value  0.05). 
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A. 3. Examination of 3H-GPC flux in methylation pathway mutant, opi3Δ cho2Δ. 
WT, opi3Δ cho2Δ and opi3Δ cho2Δ gpc1Δ containing EV or Gal1-GPC1 were used in this study. 
Cultures were pregrown in synthetic medium containing 100 M choline. Cultures were restarted 
to log phase in synthetic medium lacking uracil, inositol and choline, and containing 2% galactose, 
200 M 3H-GPC, and 200 M KH2PO4. The experiment was performed similarly to as described 
in Fig A. 2. The opi3 cho2 resulted in decreased intracellular fraction and an increased 
membrane fraction when compared to the WT. This result suggests that 3H-GPC was used for PC 
synthesis either through GPC1 or through the Kennedy pathway. The fact that loss of GPC1 in 
opi3Δ cho2Δ results in a decreased flux of 3H-GPC to 3H-PC suggest that the GPC1 was a key 
player in for PC synthesis upon disruption of methylation pathway. However, the results for opi3Δ 
cho2Δ gpc1Δ and WT do not look similar, and this suggests that a portion of 3H(choline) -GPC 
was hydrolyzed to 3H-choline for PC synthesis via the Kennedy pathway. As upon overexpression 
of GPC1 in opi3Δ cho2Δ gpc1Δ did not result in in increased membrane incorporation, this strain 
was not pursued for further metabolic studies. Experiments were performed in 3 biological 
replicates.  
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A. 4. Examining the intracellular metabolites in various mutants.  
The growth condition, media and the labeling approach were similar as described in Fig A. 2. The 
water-soluble choline-containing metabolites were separated using anion exchange 
chromatography as described in [88]. The intracellular fractions were diluted 5-fold in deionized 
H2O, applied to a 250 μl Dowex 50Wx8 200-400 cation exchange column. [3H] GPC was eluted 
with a 1 ml and 2 ml H2O washes. If present, [
3H] choline phosphate was eluted with a subsequent 
3 ml H2O wash. [
3H] choline was eluted with 5 ml HCl wash. Standards were used to verify the 
separation procedure and label incorporated into each metabolite was quantified using liquid 
scintillation counting. In almost all the strains, most of the water-soluble label was detected as 
GPC. Upon overexpression of GPC1 in all strains, there was a significant decrease in GPC fraction, 
suggesting that it is used in PC synthesis. The experiments were performed in biological triplicate.  
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A. 5. A 32P labeling to investigate the impact of Gpc1 on total PC content.  
WT (BY4742) and gpc1Δ strains containing either empty vector (pYES 2.1) or GAL1-GPC1 
(pYES 2.1-YGR149w) were employed. Cultures were maintained aerobically at 30°C in yeast 
nitrogen base (YNB) with 2% galactose and amino acids as described in [87], but lacking uracil to 
maintain the plasmids. The medium lacked inositol and contained a normal KH2PO4 level (7 mM). 
For labeling experiments, the medium was supplemented with 5 μCi/ ml of 32P (inorganic 
phosphate) and grown to log phase before harvesting. Phospholipids were isolated using the lipid 
extraction protocol described in [88]. Various control strains were used as markers to identify the 
four major types of phospholipids pertaining to our study (PC, PS, PI, PE). Normal silica gel TLC 
plates were used in this study. The mobile phase that was used for the separation of phospholipids 
is chloroform:ethanol:water:triethylamine (30:35:7:35). The 32P screen was exposed for two hours 
before imaging in Typhoon scanner 8600. Image Quant software was used to quantify the 
phospholipid spots. Unlike following radiolabeled [3H]GPC incorporation, P32 incorporation adds 
label to all phospholipids. The preliminary results suggest that the GPC acylation pathway does 
have a small impact on the total PC level. Overall, this experiment shows that the novel pathway 
is not responsible for the bulk synthesis of PC. This will need to be repeated with replicates to 
obtain a statistical significance to the generated data.  
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A. 6. Gpc1 lacks LPC acyltransferase activity in vitro.  
Microsomes from WT, ale1Δ and ale1Δ gpc1Δ EV or GAL1-GPC1 were used in this study. 
Microsomal membranes were prepared as described in [50]. Microsomal membranes 
corresponding to 20 µg total protein were incubated together with 10nmol 18:1- LPC, 10 nmol 
[14C]18:1-CoA and 0.1M phosphate buffer, pH7.2, in a total volume of 50µl at 30°C with shaking. 
LPC were added to the assay dissolved in phosphate buffer. The microsomal assays were 
terminated after 4 minutes by addition of 170 μl of 0.15M acetic acid and 500 μl of CHCl3:MeOH 
(1:1, v/v) and vortexed. After centrifugation the chloroform phase was transferred to a new tube 
and an aliquot was taken to liquid scintillation counting of the radioactivity. The remaining 
chloroform was applied on a TLC plate (Silica 60, Merck) and developed in 
CHCl3:MeOH:HAc:H2O (85:15:10:3.5 v/v/v/v). Radiolabelled lipids were identified by Rf values 
of authentic standards, and the relative amount of radioactivity in each spot was determined by 
Instant Imager (Canberra Packard Instrument Co.) electronic autoradiograph. Absolute amounts 
of radioactivity in each spot were calculated from the total amount of radioactivity in the 
chloroform phase as determined by liquid scintillation. Microsomes were incubated with LPC and 
[14C]18:1-CoA . Lipid samples were then separated and detected using TLC and Typoon scanner 
respectively. Data represent 3 independent cultures +/- SD. This experiment was performed by Dr. 
Ida Lager.  
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A.7. Loss of GPC1 affects growth in synthetic medium lacking inositol.  
The WT, gpc1Δ, cho2Δ pct1Δ, cho2Δ pct1Δ gpc1Δ, opi3Δ cho2Δ, and opi3Δ cho2Δ gpc1Δ were 
used in this study. Start-up cultures were grown in synthetic medium lacking inositol and choline. 
Cultures were restarted in 350 μl of fresh medium at 0.005 ODU’s in a 48 well plate. Growth was 
monitored at A600 nm for 40 hours using spectramax plate reader using the end program. Loss of 
GPC1 resulted in a slower growth as compared to the WT strain. The cho2Δ pct1Δ strain grows 
slower than the WT due to the attenuation in the major pathways for PC synthesis. Also, the triple 
deletion (cho2Δ pct1Δ gpc1Δ) worsened the growth defeats. Finally, as expected the opi3Δ cho2Δ 
and opi3Δ cho2Δ gpc1Δ mutants slowed a severe growth defect in medium lacking inositol and 
choline. 
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A. 8. Inhibition of sphingolipid biosynthesis affects GPC1 expression and impacts growth: A, 
B. The indicated strains were grown to log phase, cells were harvested, and RNA was extracted. 
The Gpc1 transcript were quantified using qRT-PCR. To inhibit sphingolipid biosynthesis, we 
employed myriocin at a concentration of 2.5 μM, which inhibits the serine palmitoyltransferase, 
Lcb1 [132]. Similarly, treatment of cells with myriocin resulted in a roughly 50% increase in GPC1 
message (Fig. A. 8. A). Similar upregulation of GPC1 transcript were seen in the ypk1 mutant 
that is known to have perturbation with sphingolipid synthesis. C. Strains were cultured in 
synthetic medium. 10-fold serial dilutions were spotted onto plates containing (2.5 μM) or lacking 
myriocin. These plates have been repeated twice in biological replicates.  
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A. 9. Gpc1 is predominantly localized to ER and vacuoles.  
A. Cultures were maintained in synthetic medium lacking inositol. Start-up cultures were started 
in synthetic medium lacking both inositol and choline, next day, cultures were diluted back to 0.2 
ODU and allowed to grow for 3 hours before the microscopy. The CMAC dye and Sec61-
MCHERRY plasmid were the markers for vacuoles and ER, respectively. I was able to determine 
the localization of Gpc1 in gpc1 containing the TEF1-GPC1-GFP plasmid but was unable to be 
determined it in WT strain containing TEF1-GPC1-GFP. We found that upon overexpression of 
GPC1 there was an increase in cell death in WT strain. Gpc1 was found to be localized 
predominantly at the ER. B. Cultures were maintained in synthetic medium lacking inositol. Cell 
viability was determined using trypan blue assay. The WT containing TEF1-GPC1-GFP showed 
a 2-fold increase in cell death when compared to WT+EV.  
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A. 10. GPC1 expression is upregulated by non-fermentative carbon source and in a cho2Δ 
pct1Δ mutant.  
The WT and cho2Δ pct1Δ strains were employed in this study. Cultures were maintained 
aerobically at 30°C with shaking or on a roller drum. Media used in this study were Yeast nitrogen 
base (YNB) with 2% ethanol/2% glycerol or 2% glucose and amino acid composition as described 
in [87]. Cultures were grown to log, harvested and RNA was extracted. GPC1 transcripts were 
quantified using qRT-PCR. Upon the utilization of ethanol/ glycerol as the carbon source, the 
GPC1 expression increased more than 7-fold in WT strain. The expression for GPC1 in cho2Δ 
pct1Δ is 3-fold higher to the WT when growth in medium containing glucose, but this effect was 
elevated to 13-folds upon switching the carbon source from glucose to ethanol/ glycerol. Data 
represent an average of 3 independent cultures ± SD. A t-test was performed to determine 
significance as indicated (*p-value  0.0005).  
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A. 11. Overexpression of GPC1 increases monounsaturated PC species at the expense of 
diunsaturated PC species.  
The indicated strains were grown to log phase, cultures were harvested, and lipids were extracted. 
PC species were separated and analyzed as described in methods of chapter 3. Our earlier finding 
suggested that the loss of GPC1 resulted in decreased monounsaturated PC species at the expense 
of diunsaturated PC species. To confirm this finding, we repeated the experiment by 
overexpressing GPC1 in gpc1Δ. The overexpressing of GPC1 in gpc1Δ strain resulted in increased 
monounsaturated PC species at the expense of diunsaturated PC species. Similar overexpression 
data was obtained in a WT strain that was used for the publication (Chapter 3).  Data are average 
of 3 independent cultures ± SD.  
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Experiments A. 12 and A. 13 were performed as a collaborative project with Dr. Todd Reynolds. 
This data is also in reference [134] 
 
 
 
BTY57 (WT SC5314), PEM1Δ/Δ PEM2Δ/Δ, and PEM1Δ/Δ::PEM1 PEM2Δ/Δ::PEM2 strains were 
employed in this study. Cultures were maintained aerobically at 30°C in yeast nitrogen base (YNB) 
containing 2% glucose and lacking amino acids as strains were prototrophic. For labeling 
experiments, medium was supplemented with 100 μM of choline, 5 μM of ethanolamine and 
0.1μCi/ml of 14C ethanolamine (Cat. no ARC3845). See strain table in publication. Cultures were 
grown to logarithmic phase, and 20 ODU’s of cells were harvested and the cell pellets were treated 
with 5% trichloroacetic acid (TCA) for 20 min on ice. The supernatant was discarded, and cell 
pellets were incubated at 60°C for 60 minutes with 1 ml of ESOAK (95% ethanol, diethylether, 
H2O, pyridine, NH4OH (28-30%); 15:5:15:1:0.036 v/v/v/v). The tubes were centrifuged to pellet 
the debris and 1 ml of lipid-containing supernatant were transferred to fresh tubes containing 1 ml 
of chloroform/methanol (2:1) and 0.25 ml of 0.1 M HCl. Following vortexing and low speed 
centrifugation, the bottom layers containing glycerophospholipids were dried under N2. Lipids 
were then suspended in chloroform/methanol (2:1). Lipids representing equivalent amounts 
(approximately 1.5 ODU’s) were spotted onto the Silica Gel TLC Plates (Whatman, Millipore 
Sigma 105626). The mobile phase that was used for the separation of phospholipids was 
chloroform: ethanol: water: triethylamine (30:35:7:35). TLC plates were imaged using a Typoon 
scanner 8600. Image Quant software was used to quantify the regions of intensity (ROI) for PE. 
The experiment was performed in biological triplicates and was repeated to confirm the results.  
The pem1Δ/Δ pem2Δ/Δ mutant shows the expected buildup of radiolabeled ethanolamine in PE, 
but not in PC.  Reintegration of single copy of PEM1 and PEM2 in pem1Δ/Δ pem2Δ/Δ mutant 
resulted in an increase in PC synthesis. The [14C] ethanolamine labelling experiment was 
performed to confirm that the knockout strains, pem1Δ/Δ pem2Δ/Δ and ept1Δ/Δ, display disrupted 
PC and PE biosynthesis, respectively. Pem1 and Pem2 have phosphatidylethanolamine 
methyltransferase activity that are required for conversion of PE to PC via the methylation pathway. 
Loss of these genes resulted in disruption of the methylation pathway, and in turn resulted in 
decreased PC synthesis.  An unpaired t-test was performed. P-values as denoted. 
A. 12. The pem1Δ/Δ pem2Δ/Δ mutant fails to produce PC via the CDP-DAG pathway. 
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Cultures were grown to log phase in minimal medium containing [14C] ethanolamine. 
Phospholipids were extracted and analyzed as described in (A. 12). Incorporation of the radiolabel 
into PE were quantified. Loss of EPT1 resulted in no or minimal incorporation of [14C] 
ethanolamine to PE, and the reintegrated ept1Δ/Δ::EPT1 showed PE incorporation similar to that 
of WT. The overexpresser ept1Δ/ΔPENO1-EPT1 and Peno1-EPT1 resulted in greater PE synthesis 
when compared to WT. Ept1 has ethanolamine phosphotransferase activity that is crucial in the 
CDP-ethanolamine pathway for PE synthesis. Loss of EPT1 resulted in blocked CDP-
ethanolamine pathway, and, in turn, resulted in decreased PE synthesis Experiment was performed 
in biological triplicates. An unpaired t-test was performed (*p< 02). 
 
 
 
 
 
 
 
 
 
 
A.  13. Loss of EPT1 results in diminished PE synthesis. 
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Figure A.14- A.16 represent data for a collaborative project with Dr. Allyson O’Donnell. Some or 
all the data will be included in a manuscript that is in preparation.  
 
 
 
 
 
 
 
WT and aly1Δ aly2Δ with/ without the empty vector or TEF1-GIT1-GFP plasmid were used in this 
study.  Cultures were grown aerobically at 30°C in synthetic medium lacking inositol and choline 
and containing 10mM inorganic phosphate (high phosphate) to logarithmic phase. In brief, cells 
were washed with water and resuspended in 100 mM citrate buffer, pH 5 to A600 = 5. The assays 
were initiated by adding 50 μL of 25 μM of [3H]GPI to 200 μL of cell suspension). After 5 minutes 
of incubation at 30°C, the assays were stopped by the addition of ice-cold DI H2O. Samples were 
filtered over Whatman GFC filters (Whatman number 1822-025). Filters were washed with 10 ml 
of ice cold DI H2O before suspending in 10 ml of scintillation fluid for counting using liquid 
scintillation counter [76]. The TEF1-GIT1 construct resulted in a massive increase in the transport 
of GPI in both WT and aly1Δ aly2Δ strains (grey bars). Experiments were performed in biological 
triplicate, and a t-test was performed to determine the significance. P-value ≤ 0.0001. 
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A. 14. [3H]GPI transport assays confirms the function of the overexpression construct. 
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Transport assays were performed over 5 min of uptake in WT and aly1Δ aly2Δ strains. Cultures 
were grown overnight at 30°C in synthetic medium lacking inositol and choline supplemented and 
containing 200 μM inorganic phosphate (low phosphate). The following day, single cultures were 
used to reinoculate two fresh cultures containing either 100 μM (low) or 10 mM (high) levels of 
inorganic phosphate at an A600 of 0.2. All cultures were grown to an A600 of 0.5 at which point 
they were harvested and assayed for transport activity. WT (BY4741) and aly1Δ aly2Δ cultures 
(biological triplicates) were grown aerobically overnight at 30°C in yeast nitrogen base (YNB) 
medium altered to lack inositol, contain a low level of KH2PO4 (200 μM), and to contain 2% 
glucose. Amino acid concentrations were as described [87]. The medium lacked inositol (I-) and 
contained a low KH2PO4 level to induce expression of the GIT1 transporter for GPI uptake. The 
overnight cultures were diluted to log phase in fresh medium containing a high level of KH2PO4 
(10 mM Pi) and allowed to double. To begin labeling, 4 ml cultures normalized to OD600 =0.2 were 
spiked with 5µM [3H]GPI (100,00 cpm/ml). The cultures were harvested following aerobic growth 
at 30°C for 5 hours (OD600 range of 1.3-1.5). A membrane fraction, a TCA-extractable intracellular 
fraction and an extracellular fraction were isolated as described previously [88]. The percentages 
of radioactive counts in each fraction were determined using a liquid scintillation counter. Lipids 
were extracted from the membrane fraction and separated by TLC. Radioactive (American 
Radiolabeled Chemicals Inc.) and nonradioactive (Avanti Polar Lipid) phosphatidylinositol (PI) 
standards were used to verify the migration of PI on the TLC plate. Tritium labeled GPI 
([3H]inositol-GPI) was produced through the deacylation of  phosphatidyl[3H]myo-inositol, as 
described in chapter 2. aly1Δ aly2Δ showed an increase in GPI incorporation in both low and high 
phosphate condition, when compared to the WT. Experiments were performed in biological 
triplicate, and a t-test was performed to determine the significance. P-value ≤ 0.0001. 
  
A. 15. Loss of ALY1 and ALY2 results in an increase in the GPI transport in both low 
and high phosphate medium. 
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 WT (BY4741) and aly1Δ aly2Δ cultures were grown aerobically overnight at 30°C in yeast 
nitrogen base (YNB) medium altered to lack inositol, contain a low level of KH2PO4 (200 μM), 
and to contain 2% glucose. Amino acid concentrations were as described [88]. The medium lacked 
inositol (I-) and contained a low KH2PO4 level to induce expression of the GIT1 transporter for 
GPI uptake. The overnight cultures were diluted to log phase in fresh medium containing a high 
level of KH2PO4 (10 mM Pi) and allowed to double. To begin labeling, 4 ml cultures normalized 
to OD600 =0.2 were spiked with 5µM [
3H]GPI (100,00 cpm/ml). The cultures were harvested 
following aerobic growth at 30°C for 5 hours (OD600 range of 1.3-1.5). A membrane fraction, a 
TCA-extractable intracellular fraction and an extracellular fraction were isolated as described in 
chapter 2. The percentages of radioactive counts in each fraction were determined using a liquid 
scintillation counter. Lipids were extracted from the membrane fraction and separated by TLC. 
Radioactive (American Radiolabeled Chemicals Inc.) and nonradioactive (Avanti Polar Lipid) 
phosphatidylinositol (PI) standards were used to verify the migration of PI on the TLC plate. The 
transport data indicate aly1Δ aly2Δ mutants display increased Git1 transport activity.  Since the 
inositol moiety of the Git1 substrate, GPI, is used for the synthesis phosphatidylinositol (PI), we 
wished to examine how loss of Aly and Aly2 would impact the flux of label from exogenously 
supplied 3H-GPI to 3H-PI in the absence of GIT1 overexpression. Thus, cells were first grown 
under low phosphate conditions to induce expression of GIT1. For the labelling period, cells were 
shifted to high phosphate conditions, where GIT1 expression is transcriptionally and 
posttranscriptionally, downregulated. As shown in A. 15, an aly1Δ aly2Δ mutant incorporates a 
greater percentage of label form exogenous GPI into the cell as both a TCA-extractable (water-
soluble) fraction and into a particulate membrane fraction as compared to wild type over the 
labeling period. Consistent with this, roughly 2.5 more 3H-PI was found in aly1Δaly2Δ as 
compared to wild type when lipids were extracted from the membrane fractions and resolved by 
TLC. This result is consistent with increased stability, and hence activity, of Git1 at the plasma 
membrane of aly1Δ aly2Δ cells during the labeling period. It’s important to note that the PI 
detected is not a measure of total PI, but the [3H]PI derived from exogenously supplied [3H]GPI. 
Data represent average  SD of three individual cultures (biological triplicates). 
A. 16. aly1Δaly2Δ mutant exhibits an increased incorporation of radiolabel into 
membrane fraction compared to WT. 
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Common Strain table 
 Strain Genotype Reference 
 
JPV 399 
 
 
JPV 788 
 
JPV 125 
 
JPV 834 
 
JPV 272 
 
JPV 839 
 
JPV 271 
 
 
JPV 828 
 
 
JPV 841 
 
JPV 269 
 
 
JPV680 
 
 
JPV 827 
 
 
 
JPV 270 
 
JPV 832 
 
 
JPV 833 
 
JPV 846 
 
 
WT, BY4742 
 
 
gpc1Δ 
 
gde1Δ 
 
gde1Δ gpc1Δ 
 
cho2Δ pct1Δ 
 
cho2Δ pct1Δ gpc1Δ 
 
opi3Δ cho2Δ 
 
 
opi3Δ cho2Δ gpc1Δ 
 
 
pct1Δ gpc1Δ 
 
cho2Δ 
 
 
plb1Δ plb2 Δplb3 Δ nte1 Δ 
 
 
plb1Δ plb2 Δplb3 Δ nte1 Δ 
gpc1 Δ 
 
 
pct1Δ 
 
ale1Δ 
 
 
ale1Δ gpc1Δ 
 
WT+GPC1-3xHA 
 
 
BY4742; MATα his3∆1 leu2∆0 lys2∆0 
ura3∆0 
 
BY4742; gpc1::KanMX 
 
BY4742; gde1::KanMX 
 
JPV 125; gpc1::URA3 
 
BY4742; cho2:: KanMX pct1::LEU2 
 
JPV 272; gpc1::URA3 
 
BY4742; cho2:: KanMX opi3::LEU2 
 
 
BY4742; cho2:: KanMX opi3::LEU2 
gpc1::HPHmx 
 
JPV 788; pct1::LEU2 
 
BY4742; cho2::KanMX 
 
 
his3∆1 leu2∆0 met15∆0 ura3∆0  
plb1::hph,plb2::KanMX,plb3::nat,nte1::ble
1 
his3∆1 leu2∆0 met15∆0 ura3∆0  
plb1::hph,plb2::KanMX,plb3::nat,nte1::ble
1, gpc1::LEU2 
 
BY4742; pct1::LEU2 
 
Mat a:  his3∆1 leu2Δ0 met15∆0 ura3∆0 
ale1::KANMX 
 
JPV 832; gpc1::KANMX 
 
BY4742; GPC1-3xHA 
 
Research 
Genetics 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
Strain 
database 
 
Strain 
database 
 
This study 
 
Research 
Genetics 
 
Strain 
Database 
 
Strain 
database 
 
Research 
Genetics 
 
[52] 
 
 
[52] 
 
This study 
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